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Pin1 is a peptidyl-prolyl cis/trans isomerase which catalyzes the isomerization of 
phosphorylated Ser/Thr-Pro peptide bonds. Pin1 knockout mice have marked 
abnormalities in their reproductive development and function. However, the 
molecular mechanisms underlying their reproductive defects are poorly understood. In 
this study, it has been demonstrated that Pin1 is required for both basal and 
GnRH-induced gonadotropin β subunit gene transcription through physical and 
functional interactions with the transcription factors SF-1, Pitx1, and Egr-1. Pin1 
activates transcription of the gonadotropin β subunit genes synergistically with these 
transcription factors, either by modulating their stability or by increasing their 
protein–protein interactions. Notably, it has been shown that Pin1 is required for the 
Ser 203 phosphorylation-dependent ubiquitination of SF-1, which facilitates 
SF-1–Pitx1 interactions and therefore results in an enhancement of SF-1 
transcriptional activity. It has also been demonstrated that in gonadotrope cells 
sufficient levels of activated Pin1 are maintained through transcriptional and 
post-translational regulation by GnRH-induced signaling cascades. These results 
suggest that Pin1 functions as a novel player in GnRH-induced signal pathways and is 
involved in gonadotropin β subunit gene transcription by modulating the activity of 
various specific transcription factors. In addition, in this study it has been shown that 
Pin1 can complex with the αGSU gene transcription factors, c-Jun and ATF3, and 
increase the protein level of ATF3 in gonadotropes. These findings would lay the 
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CHAPTER 1   INTRODUCTION 
1.1 Gonadotropins 
1.1.1 Pituitary gland and gonadotropes 
The pituitary gland is functionally connected to the hypothalamus via the pituitary 
stalk, through which the release of pituitary hormones is regulated by hypothalamic 
hormones. The pituitary is composed of two anatomically and functionally distinct 
lobes: anterior pituitary and posterior pituitary. The anterior pituitary gland consists of 
five distinct cell types that synthesize and secrete a variety of peptide hormones 
regulating stress response, sex organ function, thyroid gland function, milk production, 
and growth. One of these specialized cell types, the gonadotropes, synthesizes and 
secretes two distinct hormones (gonadotropins): luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) (Nussey and Whitehead, 1999).  
1.1.2 Gonadotropins and their biological functions 
LH and FSH are heterodimeric glycoproteins comprising two noncovalently 
associated subunits: a common α glycoprotein hormone subunit (αGSU) and a 
hormone specific β subunit (LHβ or FSHβ) (Pierce and Parsons, 1981). Although it is 
the unique β subunit that confers the biological specificity of each hormone, full 




LH and FSH are integral components of the mammalian reproductive axis in both 
male and female, binding to their specific receptors on the testes and ovaries to 
stimulate steroidogenesis and gametogenesis. In males, LH stimulates Leydig cells in 
the testes to synthesize and secret steroid hormones, especially androgens, while FSH 
acts on the Sertoli cells to stimulate spermatogenesis. In females, LH is required in the 
process of ovulation, luteinization, and the synthesis of progesterone and estrogen by 
the ovaries, while FSH stimulates the growth and development of ovarian follicles as 
well as promotes estrogen production by the ovaries. 
1.1.3 Regulation of gonadotropin synthesis and secretion 
The synthesis and secretion of gonadotropins are regulated by a number of factors at 
various sites along the hypothalamic pituitary gonadal axis, including gonadotropin 
releasing hormone (GnRH), steroid hormones (testosterone, estrogen and 
progesterone), and gonadal peptides (activin, inhbin and follistatin) (Pawson and 
McNeilly, 2005; Fig 1.1). The main regulator is GnRH, also known as luteinizing 
hormone releasing hormone (LHRH), which is a decapeptide neurohormone released 
by neurons within the hypothalamus in a pulsatile manner. The portal blood carries 
GnRH to the pituitary gland, which contains the gonadotrope cells. GnRH binds the 
GnRH receptor (GnRHR), a G-protein coupled seven transmembrane receptor on the 
gonadotrope cell surface, and stimulates the β isoform of phospholipase C (PLC). 
This results in the activation of a cascade of proteins involved in gonadotropin gene 




through varying pulses of different frequency and amplitude. High frequency GnRH 
pulses lead to LH release, while low frequency GnRH pulses stimulate FSH release 
(Dalkin et al., 1989; Haisenleder et al., 1988; Kirk et al., 1994). Androgens and 
estrogens act on the hypothalamus to alter GnRH pulsatility and also directly on the 
pituitary to either positively or negatively regulate LH and FSH synthesis and 
secretion (Burger et al., 2004; Luo et al., 2005). 
 
Fig 1.1: Schematic overview of the reproductive axis in male and female mammals.  
GnRH, secreted from hypothalamus, binds to GnRH receptors on the surface of the gonadotrope in the 
anterior pituitary. GnRH acts on the gonadotrope to stimulate the synthesis and secretion of LH and 
FSH, which are responsible for the synthesis of testosterone, progesterone, estrogen and inhibin by the 
testes or ovaries. High levels of testosterone, progesterone and inhibin, inhibit GnRH, LH or FSH 
secretion via a negative feedback. High levels of estrogen exert a positive feedback on GnRH at the 
time of proestrus, subsequently leading to the LH surge and ovulation. (Adapted from Brown and 




1.1.4 Immortalized murine gonadotrope cell lines 
In the gonadotrope cell lineage, expression of αGSU is initiated at approximately 
embryonic day 11.5 (e11.5) in the mouse, and LHβ and FSHβ are expressed at e16.5 
and e17.5, respectively (Japon et al., 1994). In order to generate immortalized 
gonadotrope cell lines representing gonadotropes at these different developmental 
stages, the αGSU and LHβ gene promoters were utilized to direct expression of the 
oncogenic SV40 T antigen in gonadotrope cells from e11.5 and e16.5 mouse pituitary, 
respectively (Windle et al., 1990; Alarid et al., 1996). The αT3-1 cell line represents 
the early gonadotrope (e11.5) that is not fully differentiated and expresses αGSU, 
GnRH receptor and transcription factors steroidogenic factor-1 (SF-1), pituitary 
homeobox 1 (Pitx1) and early growth response factor 1 (Egr-1), but does not express 
either the LHβ or the FSHβ gene (Windle et al., 1990). The LβT2 cell line represents 
the mature gonadotrope (e16.5) that is fully differentiated and expresses the GnRH 
receptor, SF-1, Pitx-1, Egr-1, and all of the three gonadotropin subunit genes 
(Turgeon et al., 1996). These two immortalized cell lines provide useful model 
systems to investigate gonadotrope development at different stages or transcriptional 







1.2 Basal and GnRH-induced gonadotropin subunit gene transcription 
Transcriptional regulation of the gonadotropin subunits involves two key mechanisms, 
namely basal and GnRH-induced gene expression (Fig 1.2). Basal gene expression is 
maintained throughout development, whereas the second mechanism is activated 
during the reproductive years. GnRH-induced signaling to the LH and FSH subunit 
genes is predominantly via the protein kinase C (PKC) pathway and downstream 
mitogen activated protein kinase (MAPK) cascades, including extracellular signal 
related kinase 1/2 (ERK 1/2), Jun N-terminal kinase (JNK), p38 MAPK and big 
MAPK (BMK or ERK5), while protein kinase A (PKA) is also activated following 
GnRH-induced increase in cyclic AMP (cAMP) (Naor, 2009; Lim et al., 2009). 
Activated MAPKs and PKA phosphorylate downstream cytoplasmic protein kinases 
and ultimately target transcription factors to upregulate gonadotropin subunit gene 
expression. GnRH signaling also induces the release of calcium from intracellular 
stores which activates calmodulin, stimulating downstream calmodulin kinases and 
the phosphatase calcineuin, which play a crucial role in the derepression of the FSHβ 



































































































































































































































































































































































































1.2.1 Transcriptional regulation of the αGSU subunit 
The αGSU, the common subunit of the glycoprotein hormones (LH, FSH and thyroid 
stimulating hormone (TSH)), is expressed in the gonadotropes and thyrotropes of the 
pituitary and in the trophoblasts of the placenta. Cell or tissue-specific expression of 
αGSU is determined by distinct sets of cis-acting elements along with their cognate 
binding factors (Maurer et al., 1999). Cis-elements residing in the promoter that 
contribute to gonadotrope-specific αGSU gene transcription include the E boxes, 
Pitx1 binding element, gonadotrope specific element (GSE), cAMP response element 
(CRE) and pituitary glycoprotein hormone basal element (PGBE) (Jorgensen et al., 
2004; Fig 1.3).  
 
Fig 1.3: Schematic model of several elements defining the αGSU expression. 
In the gonadotropes, specific promoter elements and their cognate binding factors are responsible for 
αGSU gene expression. The transcription of the αGSU gene is stimulated by synergistic participation 
from several transcription factors, including SF-1, Pitx1 and CREB, which bind the tandem 
cis-elements. The numbers indicate bp distance upstream of transcriptional start site. Abbreviations are 




Among these cis-elements, the CRE site (5’-TGACGT(C/A)(G/A)-3’) plays an 
indispensable role in both the basal and GnRH-induced αGSU expression. It has been 
reported that transcription factors binding to the CRE on the αGSU promoter include 
CRE binding protein (CREB) and activating transcription factors (ATF) 1, 2 and 3, 
which all belong to ATF/CREB family (Drust et al., 1991; Heckert et al., 1995; 
Heckert et al., 1996; Xie et al., 2005). ATF3, which is markedly induced by GnRH in 
vivo and in the αT3-1 gonadotrope cells due to a combined role of PKC, ERK and 
JNK, was reported to activate the human αGSU promoter (Xie et al., 2005). 
Supershift assay showed that recombinant ATF3 alone or in combination with c-Jun is 
sufficient to bind to the CRE on the αGSU promoter, which provides an explanation 
for CRE-dependent GnRH-induced αGSU promoter activity, since both Atf3 and 
c-Jun have been identified as immediate early genes in response to GnRH (Xie et al., 
2005). 
Within 60 bp of the CRE are two other important regulatory elements, GSE and α 
activating element (αACT). The GSE, which resides between -220 and -202 bp of the 
mouse αGSU promoter, is a specific binding site of the orphan nuclear receptor SF-1 
and confers a minor role for GnRH- or pituitary adenylate cyclase activating 
polypeptide (PACAP)-stimulated αGSU expression (Jorgensen et al., 2004; Fowkes 
and Burrin, 2002; Fowkes et al., 2002; Fowkes et al., 2003). Over-expression of SF-1 
increases both the basal and PACAP-stimulated αGSU transcription (Fowkes et al., 
2003). GATA binding protein (GATA)-2, which binds the neighboring αACT 




gene alone or in synergy with SF-1, and mediate ERK-activation of human αGSU 
gene transcription in LβT2 cells (Fowkes et al., 2002; Steger et al., 1994).  
There are some additional fundamental elements and factors on the promoter 
responsible for αGSU gene transcription, such as PGBE, binding the member of the 
LIM homeodomain family, LH-2 or Lim3/Lhx3, which is required for the basal 
αGSU promoter activity (Schoderbek et al., 1992; Brinkmeier et al., 1998; Roberson 
et al., 1994; Bach et al., 1995). Furthermore, in αT3-1 cells, knock-down of Pitx1 
results in suppression of both Lim3/Lhx3 and αGSU gene expression, suggesting 
Pitx1 as an earlier regulator in promoting αGSU expression through both its action on 
Lim3/Lhx3 and directly binding the Pitx1 responsive element located in the αGSU 
gene promoter (Sheng et al., 1996; Tremblay et al., 1998).  
The GnRH responsive element (GnRH RE), which is located in -416 to -385 bp, 
confers robust GnRH-induced activity to the mouse αGSU gene promoter 
(Schoderbek et al., 1993). A member of the Ets family is a likely trans-acting partner 
that binds this site because over-expression of a dominant-negative form blocks the 
GnRH response (Roberson et al., 1995). Furthermore, as mentioned above, CRE, GSE 
and PGBE have also been found to provide supportive contribution to GnRH 
responsiveness. The precise control of the basal and GnRH-stimulated αGSU gene 
expression requires synergistic participation from those various cis-elements and their 




1.2.2 Transcriptional regulation of the gonadotropin β subunits 
As synthesis of the β subunit is the rate limiting step in hormone synthesis, regulation 
of the gonadotropin β subunit genes is crucial in the production of the physiologically 
active hormone. Similar to the αGSU gene, gonadotropin β subunit genes, LHβ and 
FSHβ, are also regulated by interplay between extrinsic signals and intrinsic 
regulatory elements (Fig 1.4). 
 
Fig 1.4: Schematic models of transcription factors activating rodent gonadotropin β subunit gene 
expression. 
(A) The proximal region in the LHβ gene promoter binds SF-1 and Egr-1 at two sites, and also Pitx1; 
whereas ERα is recruited via protein–protein interactions with Pitx1 and SF-1. SP1 binds further 
upstream on the promoter and is also required for the GnRH response. (B) Conserved response 
elements for AP-1 are present on the proximal promoter of FSHβ. AP-1 response elements might 
mediate GnRH stimulatory effects to the FSHβ subunit. Pitx1 has also been shown to regulate the basal 
and GnRH-induced FSHβ gene expression. Other transcription factors that have been shown to activate 
the FSHβ promoter include NFY, Lhx3 and the Smad family. The numbers indicate bp distance 
upstream of transcriptional start site. Abbreviations are given in the text. (Adapted from Melamed et al., 





The proximal 140 bp region in the mammalian LHβ gene promoters from several 
species contains a highly conserved tripartite element that binds SF-1, Egr-1 and Pitx1, 
which activate transcription individually and synergistically to mediate the basal and 
GnRH-stimulated promoter activity (Dorn et al., 1999; Halvorson et al., 1998; Quirk 
et al., 2001; Tremblay and Drouin, 1999).  
SF-1, a member of the orphan nuclear receptor superfamily, is a key regulator of 
steroidogenic and gonadotropic gene expression (Parker and Schimmer, 1997; Luo et 
al., 1994). It is expressed predominantly in steroidogenic tissues including adrenals, 
gonads, ventromedial hypothalamus, anterior pituitary, and nonsteroidogenic organ--- 
spleen (Ramayya et al., 1997). In the pituitary it is only expressed in gonadotropes 
(Ingraham et al., 1994; Asa et al., 1996). SF-1 has a predominant role in LHβ 
expression. The tandem SF-1 binding sites in the LHβ gene promoter are essential for 
the promoter activity (Keri and Nilson, 1996; Halvorson et al., 1996). Moreover, in 
the pituitaries of SF-1 knockout mice, the LHβ transcript is undetectable, while 
expression of αGSU and the FSHβ subunit are only significantly decreased (Ingraham 
et al., 1994; Ikeda et al., 1995; Shinoda et al., 1995).  
Egr-1, a zinc finger transcription factor which is also known as NGFI-A, Zif268, or 
Krox-24, binds a pair of GC-rich regions closely associated with the tandem SF-1 
binding sites in the LHβ gene promoter (Halvorson et al., 1996; Wolfe and Call, 1999; 
Tremblay and Drouin, 1999). Egr-1 is rapidly upregulated following GnRH treatment 




that it is a downstream effector of GnRH (Tremblay and Drouin, 1999). It has been 
demonstrated that the induction of Egr-1 by GnRH, which can be mimicked by the 
PKC activator phorbol 12-myristate 13-acetate (PMA), occurs through activation of 
the PKC and MAPK pathway (Dorn et al., 1999; Khokhlatchev et al., 1998).  
Pitx1 is expressed in all pituitary cell types and is essential for both anterior pituitary 
development and the synthesis of most of the pituitary hormones including the 
gonadotropins and TSH (Tremblay et al., 1998; Melamed et al., 2002). Both the 
number of gonadotropes and thyrotropes, as well as the levels of αGSU, LHβ, FSHβ 
and TSHβ transcript and protein within the individual cells, are substantially reduced 
in Pitx1-null mice (Szeto et al., 1999; Tremblay and Drouin, 1999). The first 
characterized Pitx1 binding site in the LHβ promoter is nested between the pairs of 
Egr-1 and SF-1 binding sites (Tremblay et al., 1998, Tremblay & Drouin 1999, Quirk 
et al., 2001; Melamed et al., 2006). A second functional Pitx1 region spanning 
positions −73 to −52 in the promoter was identified several years later, and Pitx1 was 
shown to stimulate LHβ gene expression via these two functional DNA-regulatory 
regions (Jiang et al., 2005). Pitx1 also plays an important role in activating SF-1, in 
which the C-teminus of Pitx1 interacts with the putative ligand binding domain (LBD) 
of SF-1 to enhance transcriptional activity of SF-1 through an apparent unmasking of 
SF-1 (Tremblay et al., 1999). The SF-1 binding site in the promoter is strictly required 
for the transcriptional synergism between Pitx1 and SF-1 on LHβ gene (Tremblay et 




be phosphorylated possibly through GnRH-stimulated kinases (Hammer et al., 1999; 
Melamed et al., 2002).  
Our group has demonstrated that the liganded estrogen receptor α (ERα) also 
regulates LHβ gene transcription, through protein–protein interactions with SF-1 and 
Pitx1 in an estrogen responsive element (ERE)-independent manner; these allow 
association of the activated ERα to the proximal promoter of mouse LHβ gene ( Luo 
et al., 2005). 
In rodents, selective promoter factor 1 (SP1) binds further upstream on the promoter 
and is also required for the GnRH response (Kaiser et al., 1998), but the ways in 
which SP1 and other factors binding the distal elements of the LHβ gene promoter 
activate LHβ transcription and mediate the GnRH response remain unclear. The 
suggested mechanism involves interaction of these factors with the proximal promoter 
binding proteins through a coactivator complex. One possible such coactivator 
appears to be the small nuclear ring finger protein (SNURF), also known as ring 
finger protein 4 (RNF4), which was shown to associate specifically with the LHβ 
promoter in chromatin immunoprecipitation (ChIP) assays and interacts with both 
SF-1 and SP1. Over-expression of SNURF increases both the basal and GnRH 
stimulated LHβ gene expression (Curtin et al., 2004). 
Compared to the LHβ, regulation of the FSHβ subunit gene transcription at the 




at very low level in LβT2 cells. Numerous studies have revealed that conserved 
response elements for activator protein-1 (AP-1) factors, c-Jun and c-Fos, are present 
on the proximal promoter of FSHβ. It was thought that AP-1 response elements might 
mediate GnRH stimulatory effects to the FSHβ subunit as both c-Jun and c-Fos are 
rapidly upregulated after GnRH stimulation (Strahl et al., 1998; Liu et al., 2002). 
However, these AP-1 elements may be not sufficient to mediate GnRH 
responsiveness to the FSHβ subunit gene in gonadotropes (Huang et al., 2001; 
Vasilyev et al., 2002). In the mouse FSHβ gene promoter, a response element 
localizing primarily to an AP-1 half site (-72/-69) and an adjacent CCAAT box which 
binds the basal transcription factor nuclear factor Y (NFY) are required for AP-1 
binding and are critical for full activation of FSHβ by GnRH. NFY and AP-1 
physically interact and co-occupy this site in gonadotropes after GnRH stimulation 
(Coss et al., 2004). Furthermore, it has been demonstrated that NFY also interacts 
functionally and physically with SF-1 via two SF-1 binding sites on the mouse FSHβ 
promoter to regulate basal FSHβ gene expression (Jacobs et al., 2003). Pitx1 has also 
been shown to regulate the basal and GnRH-induced FSHβ gene expression through 
both direct and indirect interactions with the promoter in LβT2 cells (Zakaria et al., 
2002). Other transcription factors that have been shown to activate the FSHβ 
promoter include Lhx3 (West et al., 2004) and the Smad family (Suszko et al., 2003). 
Activin, a member of the transforming growth factor β (TGFβ) superfamily of ligands, 




nucleus and binding to Smad binding elements (SBE) on the FSHβ promoter, where 
the Smads help recruit other activators and coactivators (Suszko et al., 2003). 
1.2.3 Phosphorylation of transcription factors by MAPKs 
It has been well accepted that serine/threonine residues preceding a proline 
(Ser/Thr-Pro) form one of the major regulatory phosphorylation motifs. Protein or 
peptide containing proline is able to form both the cis and trans isomers because the 
unique five-membered ring structure of the proline side chain has the ability to adopt 
either the cis or trans state of the backbone torsion angle. Most of the isomerization 
occurs in a surface-accessible bend, coil or turn of the target protein, inducing protein 
conformational change, therefore modulating the stability and/or activity of the 
protein. Conformational change mediated by cis/trans isomerization of proline after 
phosphorylation of Ser/Thr-Pro motif has been identified as an intrinsic regulatory 
switch to modulate the stability and activity of proteins involved in various cellular 
processes (Lu et al., 2007; Lu et al., 2002; Stukenberg and Kirschner, 2001). 
Many of the transcription factors involved in the transcriptional regulation of 
gonadotropin subunit genes have been shown to be activated through phosphorylation 
at the Ser/Thr-Pro motif by Pro-directed kinases including the MAPKs. Studies have 
demonstrated that SF-1 phosphorylation by MAPK at the Ser 203-Pro motif located in 
the hinge region of the protein is required for recruitment of SF-1 cofactors and 




SP1 has been reported to be directly phosphorylated by p42/p44 MAPK at Thr 453 
and Thr 739-Pro motifs both in vitro and in vivo, and this is implicated in the 
upregulation of vascular endothelial growth factor (VEGF) gene transcription 
(Milanini-Mongiat et al., 2002). Moreover, phosphorylation of SP1 at Ser 59-Pro by 
senescence-associated phosphorylated ERK 1/2 enhances p21 transcription (Kim et al., 
2009). In LβT2 cells, ERα is phosphorylated at Ser 118-Pro in the nucleus after 
GnRH treatment, leading to its rapid association with the p300/CBP-associated factor 
(PCAF) and the transcriptional activation of fosB (Chen et al., 2009). Phosphorylation 
of c-Jun at Ser 63/73-Pro motifs by activated JNK or oncogenic Ras has been shown 
to enhance its transcriptional activity towards target genes such as cyclin D1 (Lu, 
2004). c-Fos is phosphorylated by ERKs at multiple threonine residues within its 
C-terminal transactivation domain, resulting in increased transcriptional activity 
(Monje et al., 2005). Phosphorylation of Smad4 at Thr 276-Pro in the linker region by 
MAPK can result in enhanced TGF-β-induced nuclear accumulation and, as a 
consequence, enhanced transcriptional activity of Smad4 (Roelen et al., 2003). 
Collectively, phosphorylation of Ser/Thr-Pro motif is one of the most common means 
to transmit the GnRH signal from the membrane-bound GnRH receptor into the 
nucleus and stimulate gonadotropin subunit gene transcription in a precise and 







As reviewed above, the role of phosphorylation at Ser/Thr-Pro motif in modulating 
protein function through inducing conformational change has long been considered to 
act as a signal for recruitment of other proteins and/or substrates to signaling networks 
(Lu and Zhou, 2007). However, cis/trans proline isomerization is a rather slow 
conversion. A ubiquitous mechanism explaining how phosphorylation could induce 
conformational change of protein was not elucidated in detail until the identification 
of the unique and conserved peptidyl-prolyl cis/trans isomerase (PPIase) protein 
interacting with NIMA (never in mitosis A)-1 (Pin1), which specifically isomerizes 
phosphorylated Ser/Thr-Pro (pSer/Thr-Pro) motifs in a subset of proteins (Lu, 2004; 







Fig 1.5: Schematic model of the action of Pin1 in catalyzing cis-trans isomerization of 
pSer/Thr-Pro motif.  
Reversible phosphorylation of proteins on Ser/Thr-Pro motifs by Pro-directed kinases produces the 
substrate for Pin1, which alters the conformation of target proteins by catalyzing the trans to cis or the 
cis to trans isomerization, depending on specific target sites. The resulting functional changes of the 
target proteins include catalytic activity, protein dephosphorylation, protein–protein interaction, 










1.3.1 The identification of Pin1  
Pin1 was first identified as a suppressor of NIMA in Aspergillus nidulans through 
yeast two-hybrid screening (Lu et al., 1996). NIMA is an essential mitotic kinase 
which is phosphorylated at multiple Ser/Thr-Pro motifs during mitosis. The 
over-expression of NIMA in A. nidulans induces premature chromatin condensation 
and disrupts cytoplasmic microtubules, followed by cell death (Osmani et al., 1988). 
As its over-expression prevents mitotic catastrophe induced by NIMA 
over-expression, Pin1 was initially considered as a negative regulator of mitosis (Lu 
et al., 1996). Further studies revealed that Pin1 functions as a PPIase regulating 
diverse cellular processes besides cell division per se, including growth signal 
responses, cellular stress responses, cell proliferation and immune responses 
(Ranganathan et al., 1997; Stukenberg et al., 2001; Liou et al., 2002; Monje et al., 
2005; Yeh et al., 2006; Saitoh et al., 2006). 
1.3.2 The uniqueness of Pin1 amongst peptidyl prolyl isomerases  
PPIases are an evolutionarily-conserved group of enzymes that catalyze the cis/trans 
isomerization of peptidyl-prolyl peptide bonds (Göthel and Marahiel, 1999). PPIases 
are categorized into four structurally distinct subfamilies: cyclophilins (Cyps), 
FK506-binding proteins (FKBPs), parvulins and protein Ser/Thr phosphatase 2A 
(PP2A) activator PTPA (Lu et al., 2007; Yeh and Means, 2007). Pin1 belongs to 




that specifically recognizes and isomerizes the Ser/Thr-Pro motifs after their 
phosphorylation. In addition, the specificity of Pin1 is accentuated by the finding that 
phosphorylation further restrains the already slow intrinsic isomerization rate of 
Ser/Thr-Pro bonds and also renders the phsophorylated motif resistant to the isomeric 
catalysis action of conventional PPIases (Yaffe et al., 1997). 
The unique feature of Pin1 is determined by its structure. Pin1 is an approximately 18 
kDa protein, with an N-terminal WW protein binding domain (amino acids 1-39) 
which is named after two highly conserved tryptophan residues spaced 20 to 22 amino 
acids apart, followed by a C-terminal PPIase catalytic domain (amino acids 45-163); 
these two domains are connected by a short flexible linker (Macias et al., 2002; Lu et 
al., 2007). X-ray structure of Pin1-phosphopeptide complex reveals that Ser 16, Arg 
17 and Tyr 23 in the WW domain are responsible for binding the phosphate of 
pSer/Thr-Pro, and the aromatic rings of Tyr 23 and Trp 34 form an aromatic clamp to 
accommodate the ring atoms of proline in pSer/Thr-Pro (Verdecia et al., 2000). 
Structural analysis also shows that the conserved catalytic residues Lys 63, Arg 68 
and Arg 69 in the PPIase domain sequester the proline and the peptide bond 
undergoing cis/trans isomerization in the phosphorylated Ser/Thr-Pro motif, and are 
involved in the catalysis (Ranganathan et al., 1997). Thus, the N-terminal WW 
domain and C-terminal PPIase domain together form a double-check mechanism 
conferring the unique substrate specificity of Pin1, reducing the energy barrier 





1.3.3 The involvement of Pin1 in diverse biological and pathological processes 
Recent studies have uncovered that Pin1-catalyzed post-phosphorylation 
isomerization participates in various important physiological and pathological 
processes such as cell cycle control, cell signaling transduction, gene transcription, 
immune response and oncogenesis, through regulating its target protein activities 
including transcriptional activity, enzymatic activity, protein stability, subcellular 
localization, and protein–protein interaction (Lu et al., 2007; Lu and Zhou, 2007; Yeh 
and Means, 2007; Fig 1.6).  
Furthermore, Pin1 often employs multiple mechanisms to regulate its target protein, 
and/or act on multiple factors at different levels of a specific biological process under 
certain conditions (Lu and Zhou, 2007). In the following sections, the role of Pin1 in 
oncogenesis and degenerative diseases will be elaborated based on the regulation of 
distinct targets by Pin1; the reproductive abnormalities in Pin1 knockout mice will 







Fig 1.6: The involvement of Pin1 in various cellualr processes and functional targets of Pin1. 
Pin1 regulates cell cycle progression through its interactions with proteins such as cyclin D1 (Liou et 
al., 2002; Wulf et al., 2001), cyclin E (Yeh et al., 2006; van Drogen et al., 2006), PLK1 (Shen et al., 
1998; Eckerdt et al., 2005), c-Fos (Monje et al., 2005), c-Jun (Wulf et al., 2001), CDC25 (Crenshaw et 
al., 1998; Stukenberg and Kirschner, 2001; Zhou et al., 2000), and NEK6 (Chen et al., 2006); and 
influences checkpoint through p53 (Zacchi et al., 2002; Zheng et al., 2002; Wulf et al., 2002; Berger et 
al., 2005; Mantovani et al., 2007), p73 (Mantovani et al., 2004) and SIL (Campaner et al., 2005). Pin1 
also is involved in apoptosis through p53, p73, BCL2 (Basu et al., 2002), and the extra long isoform of 
BCL2 like 11 (Becker and Bonni, 2006). Some of these effects are results of changing in protein 
localization, as shown for β-catenin (Ryo et al., 2001), NFκB (Ryo et al., 2003), and cyclin D1; protein 
stability, as shown for SRC-3 (Yi et al., 2005; Wu et al., 2007), β-catenin, cyclin D1, and cyclin E; or 
transcriptional activity, as shown for c-Jun, c-Fos, p53, β-catenin, and Smad2/3 (Nakano et al., 2009). 






1.3.3.1 Pin1 and oncogenesis 
An increasing number of studies suggest that Pin1 is involved in cell growth and 
oncogenesis, and that Pin1 is prevalently over-expressed in some human cancers 
including breast, prostate and lung cancers (Liou et al., 2002; Ryo et al., 2002; Yeh et 
al., 2006; Wulf et al., 2001; Yeh et al., 2004; Ayala et al., 2003; Zheng et al., 2009; 
Fan et al., 2009). In most of these cancer tissues, Pin1 expression level closely 
correlates with cyclin D1 and β-catenin levels and also with poor clinical outcome 
(Ryo et al., 2001; Wulf et al., 2001; Ayala et al., 2003). Cyclin D1 is both 
transcriptionally upregulated and post-translationally stabilized by Pin1 (Wulf et al., 
2001; Ryo et al., 2001; Liou et al., 2002; Wulf et al., 2004). Pin1 cooperates with the 
Ras-JNK pathway to bind c-Jun phosphorylated at Ser 63/73-Pro motifs and increase 
the transcriptional activity of c-Jun towards the cyclin D1 promoter (Wulf et al., 
2001). Pin1 also binds phosphorylated Ser 246-Pro motif in β-catenin, inhibits its 
interaction with the tumor suppressor adenomatous polyposis coli protein (APC) and 
promotes its translocation into the nucleus, thus also elevating cyclin D1 gene 
expression (Ryo et al., 2001). Furthermore, Pin1 directly binds the phosphorylated 
Thr 286-Pro motif in cyclin D1 and inhibits the export of nuclear cyclin D1 into the 
cytoplasm, where it is normally degraded by ubiquitin-proteasome pathway (Diehl 
and Sherr, 1997; Diehl et al., 1997; Liou et al., 2002). Depletion of Pin1 in mice also 
leads to a phenotype bearing a resemblance to cyclin D1 knockout mice in mammary 
gland and some other tissues (Liou et al., 2002; Wulf et al., 2004). Pin1 is also 




Pin1 itself is an E2F downstream gene and its expression is enhanced by Neu/Ras 
signaling through a postitive feedback loop (Ryo et al., 2002).  
Although above mentioned evidence from cell culture and animal models support that 
Pin1 is a key player for oncogenesis, many other studies have also revealed a 
contradictory role of Pin1 in cancer as a tumor suppressor. For example, Pin1 
regulates the tumor suppressor p53 in response to DNA damage, by increasing its 
stability and transcriptional activity, stimulating p53 acetylation by p300 
acetyltransferase and promoting the efficient binding of p53 to target promoters (Wulf 
et al., 2002; Mantovani et al., 2007). Pin1 also disrupts the association between p53 
and the apoptosis inhibitor iASPP, activating the apoptotic function of p53 
(Mantovani et al., 2007). In addition, Pin1 has been found to bind the p53 family 
member, p73, on its Ser 412/Thr 442/Thr 482-Pro motifs, increasing the accumulation 
of p73 in cells under stress; Pin1 is required for p73 acetylation by p300 (Mantovani 
et al., 2004). Other studies indicating Pin1 as a tumour suppressor include the finding 
that loss of Pin1 increases the stability of two oncoproteins, cyclin E and c-Myc, and 
arrests the cells in G1/S phase (Yeh et al., 2004; Yeh et al., 2006), and that Pin1 
promotes the degradation of oncoprotein B-cell lymphoma (BCL) 6, which is 





Therefore, to date the contribution of Pin1 in tumorigenesis is still controversial and 
enigmatic. Possible explanations could be that Pin1 plays a positive or negative role in 
cancer depending on different cell type or genetic background. 
1.3.3.2 Pin1 and degenerative disease 
Pin1 knockout mice display several phenotypes including body weight loss, testicular 
and breast atrophy, retina degeneration, neuron degeneration, decreased fertility and 
decreased bone radiodensity (Zhou et al., 2000; Liou et al., 2002; Liou et al., 2003; 
Atchison et al., 2003; Lee et al., 2009), most of which are premature ageing 
phenotypes. Pin1 has been proposed to protect against the progressive 
neurodegenerative disorder Alzheimer's disease (AD), which is characterized by the 
formation of filamentous inclusions by hyper-phosphorylated microtubule associated 
protein tau and the aggregation of the amyloid-β peptide (Aβ). Pin1 binds to tau, 
promotes the dephosphorylation of tau, and restores its ability to associate with 
microtubule and accelerate microtubule assembly (Zhou et al., 2000; Lu et al., 1999; 
Liou et al., 2003). Pin1 also regulates amyloid precursor protein (APP) processing, 
thus reducing neurotoxic Aβ synthesis (Pastorino et al., 2006). A more recent study 
has demonstrated that Pin1 is involved in telomere maintenance and ageing through 
interacting with telomeric repeat binding factor 1 (TRF1), reducing the stability of 
TRF1 and its ability to bind to telomeres, resulting in gradual telomere loss (Lee et al., 
2009). In addition, the interaction between Pin1 and the growth factor adapter p66Shc, 




p66Shc mitochondrial accumulation and subsequent apoptosis, implicating that Pin1 
plays an important role in oxidative stress and ageing (Pinton et al., 2007). Taken 
together, these findings clearly indicate that Pin1-catalyzed protein isomerization is 
involved in protecting against ageing-related degenerative diseases. 
1.3.3.3 Pin1 and reproduction 
Studies on Pin1 knockout mice showed that these mice also exhibit a range of 
reproductive abnormalities, including decreased fertility, testicular atrophy and 
reduced testes size, seminiferous tubule degeneration and spermatogonial depletion 
(Liou et al., 2002; Atchison et al., 2003; Atchison and Means, 2003). Furthermore, 
female Pin1 knockout mice have a phenotype showing severe reduction in mammary 
epithelial duct development during pregnancy (Liou et al, 2002). These marked 
reproductive defects in Pin1 knockout mice, together with the known phosphorylation 
events required for gonadotropin subunit gene transcription, suggest that Pin1 might 
have a role in mammalian reproductive system through mediating gonadotropin gene 
transcription.  
1.3.4 The regulation of Pin1 activity 
As Pin1 has been shown to be involved in numerous cellular processes, Pin1 activity 
has to be tightly regulated at multiple levels under physiological conditions to ensure 
proper cell function. Firstly, Pin1 expression is mediated by the transcription factor 




2009). Secondly, the subcellular localization and function of Pin1 depend on substrate 
interaction between its WW domain and the pSer/Thr-Pro motifs of target proteins 
(Lu et al., 2002). In addition, Pin1 itself can also be regulated by phosphorylation. 
Phosphorylation at Ser 16 in the centre of the pSer/Thr-Pro binding pocket of the WW 
domain abolishes the ability of Pin1 to interact with its substrates (Lu et al., 2002). 
Pin1 has also been demonstrated to be phosphorylated at Ser 65 by Polo-like kinase 1 
(PLK1), which increases the stability of Pin1 by reducing its ubiquitination (Eckerdt 
et al., 2005). Furthermore, preliminary studies carried out by our group indicate that 
Pin1 may be both transcriptionally and post-transcripitionally regulated by GnRH in 
pituitary gonadotropes (Oh, 2007). 
1.4 SF-1 
The orphan nuclear receptor SF-1, also known as Ad4BP or NR5A1, was first 
identified as a key regulator of steroidogenic enzymes such as cytochrome P450 
steroid hydroxylases (CYPs), from where it is named, steroidogenic factor 1 
(Morohashi et al., 1992; Lala et al., 1992). Later studies have shown that SF-1 acts 
along the hypothalamic pituitary gonadal axis at multiple sites to regulate 
transcription of a set of genes related to steroidogenesis, reproduction, and sexual 
differentiation (Hoivik et al., 2010; Table 1.1). As noted above, SF-1 is one of the 
major transcription factors of αGSU, LHβ and FSHβ genes; SF-1 knockout mice have 
greatly impaired expression of the three gonadotropin subunit genes in the anterior 




Tissue Target genes 
Adrenal cortex CYP11A1, CYP11B1, CYP11B2, CYP21, DAX-1, CYP17, StAR, 
Mc2R, SCP-2 (sterol carrier protein 2) 
Ovary Inhibin α, DAX-1, CYP11A1, CYP17, StAR, CYP19, MIS, 
Oxytocin, SCP-2 
Testis CYP19, DAX-1, SRY (sex determining region Y), Vanin-1, 
CYP11A1,CYP17, StAR, SCP-2, MIS, FSHR, Sox-9, MIS 
Pituitary 
(Gonadotropes) 
LHβ, FSHβ, GnRHR, αGSU, nNOS (neuronal nitric oxide 
synthase), Inhibin α  
Ventromedial 
hypothalamus 
BDNF (brain derived neurotrophic factor), NMDAR 
(N-methyl-D-aspartate receptor)  







1.4.1 Structure of SF-1 
SF-1 is highly conserved among species from invertebrates to vertebrates. It shares 
structural homology with other members of nuclear receptor family and contains the 
classic domains of a nuclear receptor: an N-terminal DNA binding domain (DBD) 
including two zinc fingers, a hinge region with an activation function domain (AF)-1 
in its distal part, and a ligand binding domain with a conserved C-terminal AF-2 
hexamer domain (LLIEML) (Hoivik et al., 2010; Fig 1.7).  
 
Fig 1.7: Schematic model of key structural domains in SF-1. 
SF-1 possesses an N-terminal DNA binding domain which contains two zinc finger motifs (Zn I and 
Zn II) and is extended by a FTZ-F1 box, a flexible hinge region, and a C-terminal ligand binding 
domain. A nuclear localization signal is present downstream of the DBD. SF-1 is post-translationally 
modified by acetylation (A) in the DBD and Ftz-F1 box, SUMOylation (S) at Lys 119 and Lys 194, 
and phosphorylation (P) at Ser 203. Abbreviations are given in the text. (Adapted from Hoivik et al., 







Different from most of other members in nuclear receptor superfamily, SF-1 binds 
DNA as a monomer rather than as a homodimer or hetrodimer. The first zinc finger 
motif and Fushi-tarazu factor-1 (FTZ-F1) box in DBD confer this specificity to SF-1 
and are involved in the recognition of the consensus 5’-(T/C)CAAGG(T/C)C(G/A)-3’ 
in the promoters of SF-1 target genes (Ueda and Hirose, 1991; Wilson et al., 1993).  
Similar to other nuclear receptors, the LBD of SF-1 is composed of 12 helices 
(H1-H12) (Desclozeaux et al., 2002). However, SF-1 is considered to be an orphan 
nuclear receptor because to date no evidence has proven that SF-1 binds to a naturally 
occurring ligand to reach its maximum activity (Hammer et al., 1999). Although 
several phospholipids (e.g., phosphatidyl glycerol and phosphatidyl ethanolamine) 
were discovered in the large hydrophobic ligand binding pocket of SF-1 by 
co-crystallographic analyses, biochemical analyses and an LBD helix assembly have 
demonstrated that helices 1 and 12 pack against the α-helical bundle in response to 
phosphorylation of Ser 203, indicating that the SF-1 LBD adopts an active 
conformation in a ligand independent manner (Li et al., 2005; Wang et al., 2005; 
Krylova et al., 2005; Desclozeaux et al., 2002).  
The hinge region located between DBD and LBD is important for transcriptional 
activity of SF-1 as it is targeted by post-translational modifications such as 
phosphorylation and SUMOylation (Hammer et al., 1999; Komatsu et al., 2004; 




region cooperates with the AF-2 in the LBD to activate transcription of SF-1 target 
genes (Crawford et al., 1997; Hammer et al., 1999).  
1.4.2 Regulation of SF-1 transcriptional activity 
1.4.2.1 Binding with cofactors 
Although an obligatory biological SF-1 ligand has not been identified, deletion of the 
C-terminal LBD of SF-1 unmasks transcriptional activity of SF-1, suggesting that 
mimicked-effect of ligand-receptor binding could be involved in the regulation of 
SF-1 activity (Shen et al., 1994; Crawford et al., 1997; Tremblay et al., 1999). In 
addition, this C-terminal LBD in SF-1 possesses a short α-helical AF-2 domain 
(LLIEML) which is a conserved cofactor binding surface (Yussa et al., 2001). To date, 
a number of cofactors have been reported to interact with SF-1 and modulate its 
transcriptional activity (Fig 1.8). For example, the interaction between SF-1 and 
p300/CBP potentiates the transcriptional activity of SF-1 towards the CYP11A and 
LHβ genes (Monte et al., 1998; Mouillet et al., 2004). Steroid receptor coactivator 
(SRC)-1 binding to AF-2 domain in SF-1 is required for the transactivation of several 
SF-1-target steroidogenic enzyme-coding genes and the SF-1-mediated steroidogenic 
phenotype in embryonic stem cells (Crawford et al., 1997). Temporal ChIP and 
mammalian two-hybrid (M-2-H) assays have demonstrated that, in response to cAMP 
stimulation, a ternary GCN5/SRC-1/SF-1 complex forms on the CYP17 gene 




2007). On the other hand, some corepressors interact with SF-1 and inhibit its 
transcriptional activity. The atypical nuclear receptor DSS-AHC critical region on the 
X chromosome protein 1 (DAX-1) binds to the hydrophobic LLIEML motif of SF-1 
and inhibits SF-1 transactivity to its target genes, such as StAR, MIS and some CYP 
genes, through recruiting corepressors like nuclear receptor corepressor (NCoR) 
(Suzuki et al., 2003; Lalli et al., 1998; Nachtigal et al., 1998; Wang et al., 2001; 
Hanley et al., 2001; Murayama et al., 2008). The physical interaction between SF-1 
and the DEAD-box protein DP103 has also been shown to direct the relocalization of 
SF-1 to discrete nuclear bodies and repress the transcriptional activity of SF-1 (Ou et 
al., 2001; Yan et al., 2003; Lee et al., 2005). 
 
Fig 1.8: Overview of SF-1 interaction partners. 
The activity of SF-1 is regulated through its interactions with coactivators such as CBP/p300 (Monte et 
al., 1998; Mouillet et al., 2004), GCN5 (Dammer et al., 2007; Jacob et al., 2001), SRC-1 (Winnay et al., 
2006; Ito et al., 1998; Crawford et al., 1997), SRC-2 (Winnay et al., 2006), SRC-3 (Borud et al., 2002) 
and SNURF (Curtin et al., 2004); or corepressors such as SMRT (Kelly et al., 2005), Dax-1 (Suzuki et 
al., 2003; Babu et al., 2002) and NCoR (Crawford et al., 1998). Coactivators of SF-1 are represented as 
rectangles, and corespressors as ovals. Abbreviations are given in the text. (Adapted from Hoivik et al., 




1.4.2.2 Post-translational modification of SF-1 
Transcriptional activity of SF-1 is also regulated by various post-translational 
modifications. Phosphorylation of SF-1 at Ser 203 was discovered more than a decade 
ago (Hammer et al., 1999). Ser 203 is located within the AF-1 domain (PYASP) of 
the hinge region, and the mutation of this serine to alanine (S203A) greatly attenuates 
the cofactor recruitment capacity of SF-1 (Hammer et al., 1999). Both cyclin 
dependent kinase 7 (CDK7) and ERK 1/2 have been reported to be the kinase 
responsible for Ser 203 phosphorylation (Hammer et al., 1999; Lewis et al., 2008; 
Yang et al., 2009). On the one hand, CDK7 together with cyclin H and ménage à trois 
1 (MAT1) form the CDK-activating kinase (CAK) complex, which is a component of 
basal transcription factor TFIIH, thus SF-1 may be anchored to the basal 
transcriptional machinery through its binding with CDK7 (Fisher, 2005). Notably, the 
transcriptional activity of SF-1 is hampered in HD2 human cells in which the 
interaction between CAK and TFIIH is destabilized (Lewis et al., 2008). On the other 
hand, SF-1 may integrate with the ERK signal to transmit extracellular stimulation to 
downstream genes, as many of the SF-1 target genes can be induced by hormones, 
such as GnRH and adrenocorticotropic hormone (ACTH) that also activate ERK 1/2. 
For example, in LβT2 gonadotrope cells, either deletion of the SF-1 binding site in the 
αGSU promoter or pharmacological blockage of the ERK 1/2 pathway by its specific 
inhibitor U0126, significantly attenuates PMA-stimulated transcription (Fowkes et al., 
2002). It has also been reported that in Y1 adrenocortical cells, U0126 treatment 




(Mc2R) gene promoter (Winnay and Hammer, 2006). Collectively, these data have 
demonstrated the functional importance of the phosphorylation status of SF-1 to the 
expression of its downstream genes. 
SF-1 can also be SUMOylated at two conserved lysines, Lys 119 and Lys 194, which 
are adjacent to the DNA binding domain and ligand binding domain, respectively, by 
the SUMO E2 conjugating enzyme, Ubc9, and E3 ligases of the PIAS family (Yang et 
al., 2009; Chen et al., 2004; Lee et al., 2005; Komatsu et al., 2004). As observed in 
most other nuclear receptors, SUMOylation of SF-1 represses its transcriptional 
activity. SUMOylation at Lys 119 results in a marked and selective loss of DNA 
binding to non-canonical SF-1 targets, as exemplified by the inhibin α gene promoter 
(Campbell et al., 2008; Yang et al., 2009). SUMOylation at Lys 194 is also associated 
with reduced transactivation of various SF-1 target genes and has been reported to 
inhibit Ser 203 phosphorylation (Campbell et al., 2008; Yang et al., 2009), which 
indicates a link between SUMOylation and phosphorylation. 
In addition, it has been demonstrated that SF-1 is acetylated at two conserved sites. 
One of these, located in the middle of the DNA binding domain is targeted by GCN5 
and the other, localized at the KQQKK motif in the Ftz-F1 box, is targeted by 
p300/CBP. Both GCN5 and p300/CBP act as coactivators of SF-1 by affecting its 
stability, localization and/or DNA binding activity (Chen et al., 2005; Jacob et al., 
2001). It has also been shown that p300 coordinates the functional synergy between 




stimulation of SF-1 transcriptional activity by acetylation (Mouillet et al., 2004). 
Furthermore, SF-1 can be ubiquitinated, and the ubiquitinated form is associated with 
the LHβ gene promoter in gonadotropes (Chen et al., 2007; Walsh and Shupnik, 
2009). It has become increasingly apparent that the transcriptional activity of SF-1 is 
modulated by various post-translational modifications, while the relationship between 
those modifications remains unclear. 
1.5 ATF3 
ATF3, also known as LRG-21, CRG-5, or TI-241 in mouse and liver regenerating 
factor 1 (LRF-1) in rat, is highly conserved in mammals from mouse to human. It is 
an approximately 22 kDa protein belonging to the ATF/CREB transcription factor 
family (Drysdale et al., 1996). Emerging evidence indicates that ATF3 is an 
immediate early gene participating in signaling cascades to convert an extracellular 
stimulus into intracellular changes through activating or repressing gene expression 
(Chen et al., 1994; Hai et al., 1999).  
1.5.1 Induction of ATF3 by multiple signals 
Under normal culture conditions the expression level of ATF3 is relatively low, but it 
can be rapidly induced by many physiological and pathological stimuli including 
toxic chemicals such as alcohol and carbon tetrachloride (Chen et al., 1996), 
genotoxic agents such as ionizing radiation and ultraviolet (UV) light (Amundson et 




hormones such as GnRH (Xie et al., 2005). Furthermore, in animal models its 
expression is also increased in mechanically or chemically injured liver (Chen et al., 
1996), in postseizure brain (Chen et al., 1996), in ischemic/reperfused heart, kidney 
and pancreas (Chen et al., 1996; Yin et al., 1997; Okamoto et al., 2001; 
Allen-Jennings et al., 2001), in wounded skin (Harper et al., 2005), and in all dorsal 
root ganglia neurons and motoneurons after the peripheral nerve is cut (Tsujino et al., 
2000). 
Studies have shown that multiple signaling pathways including p38 MAPK, ERK, and 
JNK/stress activated protein kinase (SAPK) are involved in the induction of ATF3 in 
a cell type and signal-specific manner (Cai et al., 2000; Inoue et al., 2004; Lu et al., 
2007). In COS-1, HeLa, MEF and HEK 293 cells, activation of the p38 pathway by 
stress signal plays an important role in inducing the expression of the ATF3 gene, 
while ERK and JNK/SAPK are neither necessary nor sufficient (Lu et al., 2007). 
However, in human endothelial cells, inhibition of the JNK/SAPK signaling pathway 
by dominant negative MAPK kinase 4 (MKK4) or MKK7 has been demonstrated to 
reduce the ability of homocysteine to activate expression of the ATF3 gene (Cai et al., 
2000). Furthermore, induction of ATF3 by ionizing radiation is through p53 
dependent pathway, while UV or methyl methanesulphonate (MMS) induction of 
ATF3 does not require normal cellular p53 function (Fan et al., 2002).  
In most cases, ATF3 induction is rapid but transient. Its mRNA level is increased 




basal level after the peak increase at around 2 h (Chen et al., 1996; Wolfgang et al., 
2000; Xie et al., 2005). One of the mechanisms for the transient nature of ATF3 
induction is that ATF3 auto-represses its own gene expression through binding to an 
ATF3 binding site (5’-TGATGCAAC-3’) in its own promoter. This site, located 
immediately after the TATA box, is different from the consensus ATF/CRE binding 
site in the central residues but is required for the efficient auto-repression (Wolfgang 
et al., 2000; Mayer et al., 2008). Furthermore, ATF3 mRNA contains several AU-rich 
RNA destabilizing elements in its 3’-untranslated region and thus is unstable, with a 
30 min half life in HeLa cells (Chen et al., 1994; Beelman and Parker, 1995; Liang et 
al., 1996). Therefore, its mRNA is not able to remain at a high level after the 
induction is turned off.  
1.5.2 Binding partners of ATF3 
ATF3 bears a basic leucine zipper (bZIP) motif, which is shared by all the members 
of the ATF/CREB family. The basic region in this motif is responsible for binding to 
the ATF/CRE site in various gene promoters, while the leucine zipper is required for 
forming homodimer or selective heterodimers with other bZIP-containing proteins 
such as c-Jun and c-Fos (Hsu et al., 1992; Chen et al., 1994). The ATF3 homodimer 
represses transcription of promoters with ATF binding sites, whereas heterodimers 
with c-Jun, c-Fos or JunB activate transcription (Hsu et al., 1992; Chen et al., 1994; 
Wolfgang et al., 1997). For example, ATF3 in complex with Jun binds to and 




helper lymphocytes into IFNγ-, IL-2-, and TNFβ-secreting T helper 1 cells (Filén et 
al., 2010). In neuron-like rat pheochromocytoma PC12 cell line and superior cervical 
ganglion neurons, the combination of ATF3 and c-Jun activates the expression of the 
anti-apoptotic factor, heat shock protein 27 (HSP27), thus leading to suppression of 
JNK-induced apoptosis (Nakagomi et al., 2003). 
Besides the bZIP family, ATF3 also cooperates with other proteins to transduce 
environmental signals, regulate gene expression and change cellular function. The 
hepatitis B virus (HBV) X protein induces the expression of ATF3 and also directly 
interacts with ATF3, enhancing DNA binding potential of ATF3 for the CRE site in 
vitro and augmenting the transcriptional repression mediated by ATF3 in vivo, 
suggesting that ATF3 is involved in HBV-mediated hepatocarcinogenesis (Barnabas 
et al., 1997; Tarn et al., 1999; Barnabas and Andrisani, 2000). Following PMA 
stimulation, ATF3 and JunB direct the loading of the chromatin remodeling SWI/SNF 
complex to the AP-1 binding site on HIV-1 promoter, through their interaction with 
the ATPase subunit of the SWI/SNF complex, brahma-related gene 1 (BRG-1) protein 
(Henderson et al., 2004). After nerve injury the transcription factor SP1 interacts with 
the injury inducible transcription factors, ATF3, c-Jun and STAT3, and recruits them 
to the promoter of damage-induced neuronal endopeptidase (DINE) gene to activate 
its transcription synergistically (Kiryu-Seo et al., 2008). Other reported ATF3 binding 
partners include NFκB (Kaszubska et al., 1993), growth arrest and DNA damage 
inducible protein 153 (GADD153) (Chen et al., 1996), p53 (Yan et al., 2002; Yan et 




1.5.3 Alternative splicing isoforms of ATF3 
In addition to the diversity of cofactors, alternative splicing of pre-mRNAs encoding 
ATF3 also leads to its functional complexity in coordinating gene expression. 
Multiple ATF3 isoforms have been identified. ATF3ΔZIP from serum-stimulated 
HeLa cells lacks the leucine zipper dimerization domain and thus fails to bind to CRE, 
but activates transcription possibly by sequestering inhibitory cofactors away from the 
promoter (Chen et al., 1994). ATF3ΔZIP2a and ΔZIP2b from cells treated with 
various stimuli, such as calcium ionophore A23187, TNFα, endoplasmic reticulum 
stress, or oxidative stress, have been shown to counteract the transcription repression 
by full-length ATF3 (Hashimoto et al., 2002). ATF3ΔZIP2c and ΔZIP3 have been 
isolated from amino acid-deprived cells, and ATF3ΔZIP3 stimulates 
starvation-induced asparagine synthetase gene transcription mediated by ATF4 in a 
concentration-dependent manner (Pan et al., 2003). ATF3b, lacking the first 57 amino 
acids of ATF3 but preserving the intact bZIP domain, has been implicated in 
mediating cAMP signaling of proglucagon gene transcription in pancreatic α cells 
(Wang et al., 2003). 
1.5.4 Dichotomous role of ATF3 in oncogenesis 
The process of cancer initiation and development in different tissues is controlled by 
actions of a diverse set of oncogenic proteins and tumor suppressors that sense 




Weinberg, 2000). Increasing evidence indicates that some proteins have dichotomous 
roles in oncogenesis. For example, it has been demonstrated that TGFβ induces 
apoptosis and growth arrest in normal or less transformed cells, but facilitates 
metastatic progression in advanced tumors (Lehmann et al., 2000; Massague, 2000; 
Derynck et al., 2001; Roberts and Wakefield, 2003). Maf bZIP transcription factors 
play a dual role in both terminal differentiation and oncogenesis, depending on the 
cellular context (Pouponnot et al., 2006). Similarly, ATF3 has also been shown to 
have a dichotomous function in cancer development, and ATF3 can promote either 
apoptosis or proliferation in specific cell lines (Ishiguro and Nagawa, 2000; Bottone 
et al., 2005; Lu et al., 2006; Bandyopadhyay et al., 2006; Fig 1.10). 
 
Fig 1.9: ATF3 is able to function as both a tumour suppressor and oncogenic protein. 
ATF3 could prevent tumour growth by repressing transcription of cell cycle genes like cyclin D1 
(James et al., 2006; Lu et al., 2006) and Id1 (Kang et al., 2003; Ling et al., 2006) and cell survival 
genes like IRS2 (Dearth et al., 2007; Li et al., 2008). On the contrary, induction of metastatic mediators 
FN-1, TWIST-1, PAI-1 and uPA (Yin et al., 2008), or suppression of GADD153 (Wolfgang et al., 
1997; Fawcett et al., 1999; Maytin et al., 2001), may implicate ATF3 as an oncogenic protein. 




ATF3 was suggested to be an oncogenic protein because it is over-expressed in some 
types of human cancers like breast cancer, prostate cancer, and Hodgkin lymphoma 
(Yin et al., 2008; Pelzer et al., 2006; Janz et al., 2006). Over-expression of ATF3 
leads to increased proliferation in DU 145 human prostate cancer cells and enhanced 
motility and invasiveness of PC-3MM and ALVA human prostate cancer cells, while 
knock-down of ATF3 expression in HT29 human colon cancer cells inhibits cell 
adhesion and reduces tumor growth rate of HT29 cell xenografts (Ishiguro et al., 2000; 
Bandyopadhyay et al., 2006; Pelzer et al., 2006). However, the mechanisms through 
which ATF3 promotes oncogenesis in these cells remain somewhat obscure; its 
repression of GADD153, a member of the CCAAT/enhancer binding protein (C/EBP) 
transcription factor family known to induce apoptosis in response to stress, could be 
one of the factors allowing the survival and proliferation of cancer cells (Wolfgang et 
al., 1997; Fawcett et al., 1999; Maytin et al., 2001).  
In contrast to the above studies, some findings indicate that ATF3 can suppress 
oncogenesis. For example, ATF3 over-expression promotes apoptosis of PC3 human 
prostate cancer cells and human ovarian cancer cells (Syed et al., 2005; Huang et al., 
2008). Nonsteroidal anti-inflammatory drugs (NSAIDs) exert their anti-invasive 
activity through upregulating the expression of ATF3, while over-expression of ATF3 
reduces the size of subcutaneous HCT-116 human colorectal cancer cell xenograft 
tumors (Bottone et al., 2003; Bottone et al., 2005). In some studies the mechanisms 
behind the function of ATF3 in tumor suppression are disclosed. Induction of the 




D1 and cyclin A transcription, accelerating cell cycle exit and terminal differentiation 
of the chondrocytes (James et al., 2006; Lu et al., 2006). ATF3 is upregulated by 
TGFβ signaling via Smad3 activation in epithelial cells, and then complexes with 
Smad3 to repress the expression of inhibitor of differentiation 1 (Id1), which is 
over-expressed in many different cancers and plays an important role in cancer cell 
survival and growth (Kang et al., 2003; Ling et al., 2006). Islets from insulin 
promoter-ATF3 transgenic mice exhibit enhanced rates of apoptosis, due to the ability 
of ATF3 to inhibit the transcription of the oncogenic protein, insulin receptor 
substrate 2 (IRS2) (Dearth et al., 2007; Li et al., 2008). Furthermore, distinct from its 
function as a transcription factor, a novel role of ATF3 in stabilizing the tumor 
suppressor p53 and p73 through inhibiting their ubiquitination was uncovered recently; 
this mechanism also explains the ability of ATF3 to suppress tumor growth (Yan et al., 
2005; Yan et al., 2006; Oh et al., 2008). 
The opposing roles of ATF3 in both tumour suppression and oncogenesis have been 
further confirmed in breast cancer cell lines that share almost the same genetic 
background but have different degrees of malignancy due to genetic and/or epigenetic 
alterations. Specifically, ATF3 induces apoptosis in the untransformed MCF10A 
mammary epithelial cell line through upregulating the transcription of several genes 
in the TNF pathway, but protects the malignant MCF10CA1a breast cancer cells from 
apoptosis and promotes their motility through increasing the expression of some key 
regulators of tumor metastasis such as TWIST-1, fibronectin-1 (FN-1), plasminogen 




al., 2008). Future studies to clarify the cellular and molecular context that determines 
whether ATF3 is an oncogenic protein or a tumor suppressor could provide insights 
into the design of anti-tumor agents. 
1.6 Ubiquitination and SUMOylation pathways 
Reversible post-translational modifications by ubiquitin (Ub) and small ubiquitin 
related modifier (SUMO) are efficient ways to dynamically regulate stability, 
subcellular localization and activity of target proteins functioning in various cellular 
events such as signal transduction, DNA repair, immune response, transcription 
regulation, and chromatin remodeling (Gill, 2004; Johnson, 2004; Sun and Chen, 2004; 
Ulrich, 2005; Chen and Sun, 2009). Unlike phosphate, acetyl groups and other small 
modifiers, ubiquitin and SUMO are entire protein moieties covalently attached to 
target proteins. Ubiquitin is a small protein (76 amino acids), highly conserved among 
different eukaryotic species (Hershko and Ciechanover, 1998). SUMO proteins are 
larger, composed of approximately 108 amino acids. Although SUMO proteins share 
very little sequence identity with ubiquitin, the structures of SUMO and ubiquitin are 
virtually super-imposable, in particular, containing a C-terminal di-glycine motif 
which is required for conjugation to substrates (Bayer et al., 1998; Bernier-Villamor 
et al., 2002; Schwartz and Hochstrasser, 2003). Therefore, ubiquitin and SUMO 
proteins share similar substrate selection and conjugation mechanisms. SUMO and 




consisting of an energy-dependent activating enzyme (E1), a conjugating enzyme (E2) 
and usually a ligase (E3), which confers substrate selectivity (Ulrich, 2005; Fig 1.9).  
 
 
Fig 1.10: Overview of ubiquitination and SUMOylation conjugation pathway. 
In an ATP-dependent reaction, the modifier (shown in gray), ubiquitin or SUMO, is covalently 
conjugated to a substrate protein (shown in yellow) via a lysine residue through the sequential actions 
of the E1 activating enzyme, E2 conjugating enzyme and E3 ligase. The attachment of multiple 
ubiquitin or SUMO by E3 to the substrate, perhaps with the help of an E4, results in polymeric chain 
formation. The specific enzymes for ubiquitin and SUMO attachment are shown in the box. Dozens of 
E2 enzymes and hundreds of E3 enzymes have been discovered for ubiquitin conjugation and are 
responsible for substrate selection. In many cases, Ubc9 can SUMOylate a substrate in an E3 
independent manner; E3 is thought to increase the efficiency of the transfer of SUMO to the substrate. 






Despite a similar conjugation mechanism, ubiquitination and SUMOylation differ 
widely with respect to their biological roles as the surface charge of SUMO is distinct 
from that of ubiquitin, and SUMO proteins, having a flexible extended N-terminus, 
are around 20 residues longer than ubiquitin (Bayer et al., 1998; Bylebyl et al., 2003). 
Polymeric chain formation through linking one modifier to an internal lysine of 
another is largely observed for ubiquitin, but happens to SUMO as well (Knipscheer 
et al., 2007; Windecker and Ulrich, 2008; Tatham et al., 2008; Ulrich, 2008). In the 
following section, the functions of ubiquitination and SUMOylation, and crosstalk 
between the two modifications will be discussed in detail.  
1.6.1 Protein regulation by ubiquitination 
The well-known function of the poly-ubiquitin chain is to target its substrates for 
proteasome-mediated degradation. However, in the past few years it has been 
uncovered that seven lysines (Lys 6, Lys 11, Lys 27, Lys 29, Lys 33, Lys 48, and Lys 
63) in ubiquitin can be conjugated by another ubiquitin to form poly-ubiquitin chains 
(Ikeda and Dikic, 2008). The various Lys-linked poly-ubiquitin chains are structurally 
and functionally distinct. Poly-ubiquitin chains, at least four subunits long, linked 
through Lys 48 in ubiquitin, normally target proteins for proteasome degradation, 
whereas mono-ubiquitin or poly-ubiquitin chains linked through other lysines usually 
perform non-proteolytic functions including chromatin remodeling, protein kinase 
activation, endocytosis, and DNA repair (Chen and Sun, 2008). For example, 




at Lys 4 and Lys 79, and is associated with active chromatin state and gene expression 
(Briggs et al., 2002; Dover et al., 2002; Ng et al., 2002; Sun and Allis, 2002; Muratani 
and Tansey, 2003). Poly-ubiquitin chains linked through Lys 63, presumably acting as 
scaffolds to facilitate the assembly of protein kinase complexes, are required to 
activate NFκB pathway through attaching to the subunits of transforming growth 
factor β activated kinase-1 (TAK1) complex and inhibitor of NFκB kinase (IKK) 
complex (Adhikari et al, 2007). Upon stimulation with epidermal growth factor (EGF), 
the EGF receptor (EGFR) is multiply mono-ubiquitinated and poly-ubiquitinated 
through Lys 63 in ubiquitin, which generates internalization and sorting signals to 
lysosomes, culminating in endocytosis (Huang et al., 2006).  
It should be noted that ubiquitination is a dynamic modification which can be 
reversed by deubiquitinating enzymes (DUBs) and can undergo ubiquitin editing. The 
ubiquitin-editing enzyme, A20, which contains both N-terminal ovarian tumour 
deubiquitinase (OTU) domain and C-terminal E3 ligase domain, cooperates with the 
regulatory protein human T-cell leukemia virus type I transactivator binding protein 1 
(TAX1BP1) and the HECT domain Itchy E3 ubiquitin protein ligase homolog (ITCH) 
to attenuate the NFκB pathway. This is through removing signal-enhancing Lys 
63-linked poly-ubiquitin chains from the critical NFκB signaling molecules, including 
receptor interacting protein 1 (RIP1) and TNF receptor associated factor 6 (TRAF6), 
and facilitating the formation of signal-extinguishing Lys 48-linked poly-ubiquitin 
chains that lead to proteasomal degradation (Wertz et al., 2004; Newton et al., 2008; 




1.6.2 Protein regulation by SUMOylation 
Similar to the non-proteolytic functions of ubiquitination, SUMOylation regulates 
protein–protein interaction, subcellular localization and/or activity of a target protein, 
and is thereby involved in various cellular processes, including transcription 
regulation, cell cycle control and DNA damage response (Gill, 2004; Hay, 2005; 
Muller et al., 2004; Geiss-Friedlander and Melchior, 2007). SUMOylation modifies 
the surface of a given protein or induces its conformational change, which usually 
alters its intermolecular or intramolecular interaction specificity (Gill, 2004; Hay, 
2005; Baba et al., 2006). It is believed that most of the effects of SUMOylation on 
proteins result from its modulation of protein–protein interactions (Geiss-Friedlander 
and Melchior, 2007). For example, un-SUMOylated Ran GTPase activating protein 1 
(RanGAP1) is localized in the cytosol; SUMOylation-dependent interaction between 
RanGAP1 and the nucleoporin RanBP2, targets SUMOylated RanGAP1 to the 
nuclear pore (Mahajan et al., 1997; Mahajan et al., 1998; Matunis et al., 1998). 
SUMOylation of p300 leads to its interaction with histone deacetylase (HDAC) 6 and 
subsequent transcriptional repression (Girdwood et al., 2003). The yeast DNA 
helicase, SRS2, has a preference for interacting directly with the SUMOylated 
proliferating cell nuclear antigen (PCNA), and therefore is recruited to replication 
forks to prevent unwanted recombination of replicating chromosomes (Papouli et al., 




A distinctive feature of SUMOyaltion is that SUMO is often conjugated to the lysine 
within ψKXE (ψ denoting a hydrophobic residue) consensus motif in a target protein 
(Rodriguez et al., 2001; Bernier-Villamor et al., 2002). Some non-consensus 
SUMOylation sequences including TKET, TKED, AKCP, VKYP, VKFP and 
GKVEKVD, in which both lysines can be attached by SUMO, have also been 
reported (Johnson, 2004). Furthermore, two extended SUMOylation motifs, which 
contain regulatory information from the substrate itself, have also recently been 
identified. The first one is phosphorylation-dependent SUMOylation motif (PDSM), 
which consists of the conventional SUMOylation motif and a phosphorylated serine 
residue followed by a proline residue (ψKXEXXpSP). PDSM has been found in 
several proteins including Smad nuclear interacting protein 1 (SNIP1), heat shock 
factor 1 (HSF1), and myocyte specific enhancer factor 2A (MEF2A) (Hong et al., 
2001; Hietakangas et al., 2003; Hietakangas et al., 2006). The second one is 
negatively charged amino acid dependent SUMOylation motif (NDSM). It has been 
shown that SUMOylation of Elk-1 is inhibited by mutation of the negatively charged 
residues C-terminal to the consensus sequence (Yang et al., 2006). The identification 
of these two extended motifs highlights that negative charge next to ψKXE motif is 
functionally important to enhance SUMOylation. 
Like ubiquitination, SUMOylation is a reversible modification. SUMO can be 
removed from its substrates by sentrin specific proteases (SENPs). Only a small 
percentage of a target protein tends to be SUMOylated in vivo at a certain time point, 




(Geiss-Friedlander and Melchior, 2007). SUMO can also form polymeric chains on 
some of its target proteins such as HDAC4, SP100 nuclear antigen (SP100), and 
promyelocytic leukemia (PML) to regulate their functions (Tatham et al., 2001; 
Mukhopadhyay et al., 2006; Knipscheer et al., 2007; Lallemand-Breitenbach et al., 
2008; Tatham et al., 2008). 
1.6.3 Crosstalk between ubiquitination and SUMOylation 
It has become clear that ubiquitination and SUMOylation often communicate with 
each other to jointly regulate a common target protein (Gill, 2004; Ulrich, 2005; 
Geiss-Friedlander and Melchior, 2007). In some cases SUMO antagonizes ubiquitin at 
the same lysine residue of a target, thereby protecting the target from 
proteasome-mediated degradation. It has been demonstrated that ubiquitination of 
inhibitor of NFκB (IκB) α at Lys 21 and Lys 22, dependent on its phosphorylation at 
Ser 32 and Ser 36, targets IκBα to degradation by the 26S proteasome, thus allowing 
the translocation of NFκB to the nucleus. SUMO can also target IκBα at Lys 21, 
blocking its ubiquitination and protecting it from the degradation induced by 
inflammatory stimuli (Desterro et al., 1998; Karin and Ben-Neriah, 2000). Huntingtin 
exon 1 protein (Httex1p), a pathogenic fragment of Huntingtin, can be modified by 
either SUMO or ubiquitin at identical lysines. SUMOylation has a stabilizing effect 
on Httex1p (Steffan et al., 2004). Examples of target proteins having a common lysine 
residue targeted by both SUMO and ubiquitin also include Smad4 and PCNA (Lin et 




ubiquitin and SUMO do not compete with each other in this context. 
Mono-ubiquitination of PCNA at Lys 164 upon DNA damage in yeast does not target 
this protein for degradation but is critical for translesion synthesis repair through 
promoting its interaction with the translesion polymerase η (Hoege et al., 2002; 
Kannouche et al., 2004). SUMOylation of PCNA at Lys 164, and to a minor extent at 
Lys 127, has been shown to enhance DNA damage tolerance through recruiting the 
helicase SRS2 to the site of replication and inhibit unscheduled recombination, rather 
than prevent ubiquitin dependent activities (Stelter and Ulrich, 2003; Haracska et al., 
2004).  
Sequential actions of SUMO and ubiquitin on NFκB essential modifier (NEMO), the 
regulatory component IKK complex, also suggest that SUMO and ubiquitin can act 
cooperatively. SUMOylation of NEMO at Lys 277 and Lys 309 after exposure to 
DNA damaging agents leads to its retention in the nucleus, where the checkpoint 
kinase ATM dependent signaling induces its phosphorylation and subsequent 
ubiquitination. The ubiquitinated NEMO can then translocate back to the cytosol and 
associate with IKKα/β to form an active IKK kinase (Huang et al., 2003; Hay, 2004). 
Furthermore, it has been revealed recently that poly-SUMO chain on a target such as 
PML can serve as a binding site for the RING finger E3 ubiquitin ligase 
RNF4/SNURF, which bears four closely spaced SUMO interaction motifs (SIMs) at 
its N-terminus, to promote the ubiquitination and subsequent degradation of the target 




et al., 2008). In brief, the two modification systems, ubiquitination and SUMOylation, 
can cooperate in diverse ways to regulate a target protein.  
1.7 Hypothesis and aims 
1.7.1 Hypothesis 
Due to the fact that loss of Pin1 in mice causes severe abnormalities in their 
reproductive development and function, and that many gonadotropin subunit gene 
transcription factors are phosphorylated at Ser/Thr-Pro motifs, it is hypothesized that 
Pin1 is involved in the transcriptional regulation of the gonadotropin subunit genes 
through acting on their upstream transcription factors, and that GnRH-induced 
pathway facilitates Pin1 activity to increase gonadotropin transcription.  
1.7.2 Aims 
The specific aims of the present study are: 
1) to assess the roles of Pin1 in regulating gonadotropin β subunit gene transcription 
through examining the effects of Pin1 over-expression or knock-down on LHβ and 
FSHβ transcripts and their promoter activity in gonadotrope cells; 
2) to uncover the mechanism of Pin1 actions towards gonadotropin β subunit gene 




gene-specific transcription factors and its effects on their activity, stability and ability 
to associate with other factors; 
3) to verify the role of GnRH in regulating Pin1 activity. 
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CHAPTER 2   MATERIALS AND METHODS 
2.1 Cell culture 
2.1.1 Growth conditions 
The murine gonadotrope αT3-1 and LβT2 cells (gifts from Dr. P. Mellon, UCSD) 
were cultured in Dulbeco’s modified Eagle’s medium (DMEM) supplemented with 
10% dialyzed fetal bovine serum (FBS) (Gibco-Invitrogen), 10 mM HEPES [pH 7.4], 
4 mM L-glutamine (Hyclone), 100 U/mL penicillin (Gibco-Invitrogen) and 100 
μg/mL streptomycin (Gibco-Invitrogen). COS-1 cells, HEK 293T control siRNA cells, 
HEK 293T Pin1 siRNA cells (generated by Ms. Q. Y. Yang, NUS), MEF wild type 
(WT) cells, and MEF Pin1 –/– cells (gifts from Dr. K. P. Lu, Harvard Medical School) 
were cultured in Dulbeco’s modified Eagle’s medium supplemented with 10% 
certified FBS (Hyclone), and the same antibiotics. All cells were maintained at 37 °C 
under 5% CO2. 
2.1.2 Storing and recovery of cells 
The culture medium was removed. The cells were rinsed once with 1×phosphate 
buffered saline (PBS) and detached from dish by trypsinization. 10 mL medium was 
then added into the dish to transfer the cells to a 50 mL falcon tube. After spinning 
down at 800 rpm for 5 minutes, the medium was discarded. The cell pellet was 
resuspended with 1 mL freezing medium (90% culture medium + 10% DMSO) and 
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the 1 mL suspension was then transferred to a 2 mL cryogenic microfuge tube 
(NUNC). The tube was incubated immediately at –20 °C for 1 h, followed by –80 °C 
overnight before being stored in liquid nitrogen. 
The tube of frozen cells was placed in 37 °C water bath to thaw. The suspension in 
the tube was then directly added into 10 mL of culture medium in a 100 mm culture 
dish. The dish was swirled gently and incubated at 37 °C under 5% CO2 for 24 h 
before the cells were rinsed once with 1×PBS and fresh medium replaced. The cells 
were then grown according to the required confluency before splitting the cells to be 
used for experiments. 
2.1.3 Treatment of cells 
Some of the cells were exposed to 100 nM of the GnRH agonist, buserelin (Sigma; 
dissolved in H2O); 100 nM PMA (Sigma; dissolved in DMSO); 1 μM forskolin 
(Sigma; dissolved in H2O); 10 μM MG132 (Sigma; dissolved in DMSO); 15 μM 
roscovitine (Sigma; dissolved in DMSO); 1 μM U0126 (Promega; dissolved in 
DMSO) or 100 μg/mL cycloheximide (Sigma; dissolved in DMSO), as indicated.  
2.1.4 Transient transfection of cells 
Transfection was carried out at 50 to 60% confluence. LβT2 cells were transfected 
using GenePORTER 2 (Gene Therapy Systems), HEK 293T cells were transfected 
using the calcium phosphate method, and the other cells were transfected using 
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Lipofectamine 2000 (Invitrogen). After transfection, cells were incubated for a further 
24-48 h before harvest. 
Transfection using GenePORTER 2 or Lipofectamine 2000 was performed according 
to the manufacturers' instructions. The optimized transfection reagent to DNA ratios 
are shown in Tables 2.1 and 2.2.  
Cell type Lipofectamine 2000 (μL) : DNA (μg) 
COS-1 5 : 3 
MEF WT 5 : 2 
MEF Pin1 –/– 5 : 2 
Table 2.1: Optimized Lipofectamine 2000 (μL) : DNA (μg) 
 
Cell type GenePORTER 2 (μL) : DNA (μg) 
LβT2 7 : 2 
αT3-1 5 : 1 
Table 2.2: Optimized GenePORTER 2 (μL) : DNA (μg) 
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Calcium phosphate transfection method (for 60 mm dish) 
The HEK 293T control siRNA cells or Pin1 siRNA cells were seeded into 60 mm 
culture dishes the day before transfection to reach about 50-60% confluence at the day 
of transfection. Before transfection the medium was removed, the cells were rinsed 
once with 1×PBS, and 3 mL fresh medium was added into each dish. DNA (4 µg) was 
added to ddH2O to a total volume of 219 µL in a 1.5 mL sterile tube, and then 31 µL 2 
M CaCl2 was added to a final volume of 250 µL. After that, 250 µL of 2×HEPES 
buffered saline (2×HBS, the recipe for which as shown below) [pH 7.05] was added 
drop-wise to the DNA-CaCl2 complex, and the final mixture was then swirled gently 
to form the DNA-CaPO4 precipitate. Within 2 minutes after the addition of 2×HBS, 
the 500 µL final mixture was added directly to the cells drop-wise through the 
medium, the droplets were sprinkled evenly over the surface of the dish. The dishes 
were put back into the incubator at 37 °C under 5% CO2 for 8-10 h and then replaced 
with fresh medium. The cells were harvested 24-48 h after transfection.  
2×HBS [pH 7.05]   100 mL 
NaCl      1.6 g  
HEPES      1.0 g  
Dextrose     0.2 g  
KCl       74 mg  
Na2HPO4 (anhydrous)  21.3 mg  
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The above mixture was dissolved in 90 mL ddH2O, and then pH was adjusted to 7.05 
with NaOH. The final volume was brought to 100 mL by adding ddH2O. The solution 
was then filtered through 0.22 µM filter before being aliquoted into sterile tubes and 
kept frozen at –20 °C. 
2.2 Plasmid constructs 
2.2.1 Gonadotropin subunit gene promoter construct for luciferase assays 
The 1300 bp of the mouse proximal LHβ gene promoter, or 600 bp of the mouse 
proximal FSHβ gene promoter in pGL2 Basic (Promega) were reported previously 
(Melamed et al., 2006; Feng et al., 2008).  
2.2.2 Expression vectors 
The expression vectors for Pitx1, Egr-1, and SF-1 were gifts from J. Drouin (Montreal, 
Canada), J. Milbrandt (St. Louis, MO), and K. Parker (Durham, NC), respectively. 
pEGFP Pin1 and pEGFP Pin1 S16A were gifts from Dr. K. P. Lu (Harvard Medical 
School). The coding sequences of Pin1 and ATF3 were PCR-amplified from LβT2 
cell cDNA, and were ligated into pCS2+ expression vector. The primers used for the 
construction of pCS2+ Pin1 and pCS2+ ATF3 are shown in Table 2.3. The constructs 
were verified by sequencing (See Section 2.2.4). 
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Vector Primer Oligonucleotide sequence (5’-3’) Restriction 
Enzyme Site 
Mouse Pin1 F GCGCGAATTCATGGCGGACGAGG
AGAAG 
EcoRI pCS2+ 
Mouse Pin1 R GCGCTCTAGATCATTCTGTGCGCA
GGAT 
XbaI 
Mouse ATF3 F GCGCGGATCCATGATGCTTCAACA
TCCAG 
BamHI pCS2+ 
Mouse ATF3 R GCGCGAATTCTTAGCTCTGCAATG
TTCCT 
EcoRI 
Table 2.3: Primer sequences for pCS2+ Pin1 and pCS2+ ATF3 constructs 
For tagged constructs, sequence-specific primers containing restriction enzyme sites 
at the 5’ ends were used to PCR-amplify the DNA fragments from the above 
expression vectors. The Pin1 coding sequence was inserted into p3×Flag-CMV 10 
expression vector. Pitx1, SF-1, Egr-1 and ATF3 coding sequences were inserted into 
pxj40-HA, pxj40-Flag or pxj40-GFP (gifts from Dr. B. C. Low, NUS), as shown in 
Table 2.4. The primers used for the construction of tagged expression vectors are 
shown in Table 2.4. The pxj40-Myc SUMO-1, pxj40-Myc SUMO-2, pxj40-Myc 
SUMO-3, pxj40-Myc ubiquitin, pcDNA 3.1 HA ubiquitin K48R and pcDNA 3.1 HA 
ubiquitin K63R were constructed by Ms. Q. Y. Yang (NUS). The pcDNA3 CDK7 HA 
(P#633) and pcDNA3 CDK7 D155A HA (P#812) were purchased from Addgene. 
Site-directed mutations were carried out using the QuikChange site-directed 
mutagenesis kit (Stratagene), according to the manufacturer's instructions, in order to 
introduce the specific amino acid substitutions. The primers used for site-directed 
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mutations are shown in Table 2.5. The constructs were verified by sequencing (See 
Section 2.2.4). 
Vector Primer Oligonucleotide sequence (5’-3’)  Restriction 
Enzyme 
Site 
Pin1 F GCGCAAGCTTGCGGACGAGGAGAAG HindIII p3×Flag- 
CMV 10 Pin1 R GCGCGGATCCTCATTCTGTGCGCAGGAT BamHI 
SF-1 F GCGCGGATCCGACTACTCGTACGACGAGGAC BamHI pxj40-HA 
pxj40-Flag 
pxj40-GFP SF-1 R GCGCAAGCTTTCAAGTCTGCTTGGCCTGC HindIII 
Egr-1 F GCGCGGATCCGCAGCGGCCAAGGCCGAGATG  BamHI pxj40-HA  
Egr-1 R GCGCAAGCTTTTAGCAAATTTCAATTGTCCTGG HindIII 
Pitx1 F GCGCGGATCCGACGCCTTCAAGGGAGGCAT BamHI pxj40-HA 
pxj40-Flag  
Pitx1 R GCGCAAGCTTTCAGCTGTTGTACTGGCAAGCG HindIII 
ATF3 F GCGCAAGCTTATGCTTCAACATCCAGGCC HindIII pxj40-HA 
pxj40-Flag  
ATF3 R GCGCCTCGAGTTAGCTCTGCAATGTTCCT XhoI 
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Oligonucleotide sequence (5’-3’) Forward Amino acid 
substitution Oligonucleotide sequence (5’-3’) Reverse 
CAGAGCCCTATGCCGCCCCCCCACAACAGC SF-1 S203A 
GCTGTTGTGGGGGGGCGGCATAGGGCTCTG 
GGCCAATGGCTTCAGGCTGGAGACCGGAC SF-1 K119R 
GTCCGGTCTCCAGCCTGAAGCCATTGGCC 
TAACCGCACCATCAGGTCTGAGTATCCAG SF-1 K194R 
CTGGATACTCAGACCTGATGGTGCGGTTA 
CCTTCTTCAACTCCATGGCCCCGCTCTCCTCTC Pitx1 S207A 
GAGAGGAGAGCGGGGCCATGGAGTTGAAGAAGG 
TCAACTCGGCCATGGCGCCGGGCGCCTGC Pitx1 S259A 
GCAGGCGCCCGGCGCCATGGCCGAGTTGA 
GCCCCTACGGCGCCCCAGCCGCGCCCTACAGCGTCTA Pitx1 T267A S270A 
TAGACGCTGTAGGGCGCGGCTGGGGCGCCGTAGGGGC 
TAACCTGACACCCTTTGTCAGGGAAGAGCTGAGATTC ATF3 K42R 
GAATCTCAGCTCTTCCCTGACAAAGGGTGTCAGGTTA 
GATGTCAGTCACCAGGTCTGAGGCGGCC ATF3 K78R 
GGCCGCCTCAGACCTGGTGACTGACATC 
GTGTCGAAACAAGAGAAAGGAGAAGACAGAGTGC ATF3 K107R 
GCACTCTGTCTTCTCCTTTCTCTTGTTTCGACAC 
CGAAACAAGAAAAAGGAGAGGACAGAGTGCCTGC ATF3 K110R 
GCAGGCACTCTGTCCTCTCCTTTTTCTTGTTTCG 
GCAGAAAGAGTCAGAGAGACTGGAGAGTGTGAATGC ATF3 K120R 
GCATTCACACTCTCCAGTCTCTCTGACTCTTTCTGC 
CCAGATCGAGGAGCTGAGGAATGAGAAACAGC ATF3 K136R 
GCTGTTTCTCATTCCTCAGCTCCTCGATCTGG 
Table 2.5: Primer sequences for site-directed mutations 
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2.2.3 Constructs for the two-hybrid assays 
For the two-hybrid assays, the reporter gene construct was created as described 
previously (Luo et al., 2005). Other constructs were prepared using Gal4 DBD or 
Gal4 activation domain (AD) vectors, pM or pVP16 (Clontech). The pM Pin1 was 
constructed by A. Wijeweera (NUS); pVP ATF3 was created by inserting the ATF3 
coding sequence into pVP16; pVP SF-1, pVP Egr-1, and pVP Pitx1 were created 
previously (Luo et al., 2005; Melamed et al., 2006). Site-directed mutation was 
carried out to create pVP SF-1 S203A using the QuikChange site-directed 
mutagenesis kit and pVP SF-1 as template. The constructs were verified by 
sequencing (See Section 2.2.4).  
2.2.4 Verification by DNA sequencing 
Automated DNA sequencing (ABI Prism® 3100) was carried out to verify the correct 
sequence of all of the constructs. The primers used are listed in Table 2.6. Sequencing 
PCR reactions were assembled as stated in Table 2.7. Cycling parameters are shown 
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pxj40 T7 TAATACGACTCACTATAGGG 
pM Forward TCATCGGAAGAGAGTAG 
pVP Forward GCCGACTTCGAGTTTGAG pM/pVP16 
pM/ pVP Reverse GGTTCAGGGGGAGGTGTGGG 
Table 2.6: Primers used for DNA sequencing 
 
 
Reagent Volume (μL) 
DNA template (0.2-0.5 μg/μL) 1 
Primer (5 pM) 1 
Big dye version 3 (Applied Biosystems) 2 
5×Sequencing Buffer  2 
ddH2O 4 
Total reaction volume 10 
Table 2.7: Sequencing PCR reaction mixture 
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Segment Cycle Temperature (°C) Time 






2 1 16 ∞ 
Table 2.8: Sequencing PCR parameters 
The 10 μL of the sequencing PCR reaction containing the amplified DNA was mixed 
with 20 μL of 3M NaOAc [pH 4.6] and 50 μL of 95% ethanol before precipitating at 
–20 °C for 15 min. The sample was then centrifuged at 14,000 rpm at room 
temperature for 30 min. The supernatant was removed and the pellet was washed 
twice with 500 μL of 75% ethanol, centrifuging at top speed for 10 min after each 
wash. The DNA pellet was dried at 90 °C before automated sequencing was carried 
out on the ABI Prism 377 (Perkin Elmer) according to the manufacturer’s 
instructions.  
2.3 Antibodies 
Antibodies used in this study were as follows: anti-Pin1 (Santa Cruz; sc-15340); 
anti-HA (Santa Cruz; sc-805 and sc-7392); anti-c-Myc (Santa Cruz; sc-40) (Sigma; 
C3956); anti-Flag (Santa Cruz; sc-807) (Sigma; F3165); anti-GAPDH (Santa Cruz; 
sc-47724); anti-ATF3 (Santa Cruz; sc-188); anti-c-Jun (Santa Cruz; sc-1694); 
anti-Pitx1 (Santa Cruz; sc-18922); anti-Egr-1 (Santa Cruz; sc-110); anti-β-Catenin 
(Santa Cruz; sc-7199); anti-Ubiquitin (P4D1; Santa Cruz; sc-8017); anti-ERK1 (Santa 
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Cruz; sc-94); anti-ERK2 (Santa Cruz; sc-154); anti-phospho ERK (Tyr 204; Santa 
Cruz; sc-7976); anti-Calcineurin (PP2B-Aa (D-9); Santa Cruz; sc-17808); anti-green 
fluorescent protein (GFP) (Santa Cruz; sc-81045 and sc-8334); anti-CDK7 (Santa 
Cruz; sc-7344); anti-phospho CDK7 (T170; Abcam; ab59987); anti-SF-1 (Upstate 
Biotechnology; 07-618); anti-phospho Pin1 (Ser 16; Cell Signalling; 3721); 
anti-α-tubulin (Sigma; T9026). 
2.4 RNA-mediated knock-down of Pin1 expression  
Stealth small interfering RNA (siRNA) specific for mouse Pin1 (sense, 
5’-GCCGGGUGUACUACUUCAA[dT][dT]-3’), and scrambled control (sense, 
5’-GUGUUACAGCUCCAGAUGC[dT][dT]-3’) were purchased from Invitrogen 
(Ryo et al., 2005). The siRNA duplexes were dissolved in RNase-free ddH2O to make 
a 20 μM stock solution, aliquoted and stored at –20 °C before use. The siRNAs were 
transfected into LβT2 cells using Oligofectamine (Invitrogen). 
Transfection LβT2 cells with siRNA using Oligofectamine (for 60 mm dish) 
The gonadotrope LβT2 cells were seeded into 60 mm culture dishes in 5 mL growth 
medium containing 10% FBS without antibiotics the day before transfection to reach 
about 40-50% confluence at the day of transfection. Before transfection the medium 
was removed, the cells were rinsed once with 1×PBS, and 2.0 mL DMEM without 
antibiotics was added into each dish. 10 μL of 20 μM siRNA was gently mixed with 
200 μL Opti-MEM I medium (Invitrogen), and 10 μL of Oligofectamine was gently 
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mixed with 40 μL Opti-MEM I medium. After 5 min incubation at room temperature, 
the diluted siRNA and diluted Oligofectamine were combined (total volume 260 μL), 
mixed gently and incubated another 20 min at room temperature. The 260 µL final 
mixture was added directly to the cells drop-wise through the medium, the droplets 
were sprinkled evenly over the surface of the dish. The dishes were put back into the 
incubator at 37 °C under 5% CO2 for 4-6 h and then 2.26 mL of growth medium 
containing 20% FBS without antibiotics was added. The cells were harvested 48-72 h 
after transfection. 
2.5 Reverse transcriptase (RT)-PCR analysis 
2.5.1 RNA isolation 
Total RNA from LβT2 cells was isolated using 1 mL TRIZOL reagent (Invitrogen) 
per well for 6-well plate according to the manufacturer’s instructions. The RNA was 
used immediately or stored at –80 °C for less than one month before analysis. 
2.5.2 First strand cDNA synthesis 
First strand cDNA was synthesized from 2 μg of the isolated RNA. Annealing of 
Oligo dT12-18 (New England Biolabs) to the poly-A tail of mRNA was carried out by 
heating the reaction mixure, shown in Table 2.9, to 65 °C for 5 min and then quickly 
chilling it on ice. 
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Reagent Volume  
Oligo dT12-18 (500 μg/mL)  1 μL 
RNA (2 μg) 2 μg 
dNTP (10 mM) 1 μL 
ddH2O Top up to final volume 
Total volume 13.5 μL 
Table 2.9: First strand cDNA synthesis reaction mixure 
Subsequently, 4 μL of 5×first strand buffer, 2 μL of 0.1 M DTT and 0.25 μL RNase 
outTM (Invitrogen) was added to the chilled reaction mixure and reheated to 42 °C for 
2 min before the addition of 0.25 μL of Superscript III Reverse Transcriptase 
(Invitrogen). The mix was then incubated at 42 °C for 50 min before heat inactivation 
at 70 °C for 15 min. The cDNA was used immediately or stored at –80 °C. 
2.5.3 PCR and gel electrophoresis 
Of the 20 μL cDNA obtained, 1 μL was used for a semi quantitative PCR reaction 
with specific primers. Primers used to amplify the fragments of mouse SF-1, Pitx1 
and ATF3 cDNA with β-actin as an internal control are listed in Table 2.10. The PCR 
reactions were assembled as stated in Table 2.11. Cycling parameters are shown in 
Table 2.12. Analysis of amplicons was performed using 1% agarose gel. 
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Primer Oligonucleotide sequence (5’-3’) 
SF-1 F ATGGACTATTCGTACGAC 
SF-1 R TCAAGTCTGCTTGGCCTG 
Pitx1 F  ATGGACGCCTTCAAGGGAGGC 
Pitx1 R TCAGCTGTTGTACTGGCAAG 
ATF3 F ATGATGCTTCAACATCCAG 
ATF3 R TTAGCTCTGCAATGTTCCT 
β-actin F GCCATGTACGTAGCCATCCA 
β-actin R ACGCTCGGTCAGGATCTTCA 
Table 2.10: Primers used for RT-PCR analysis 
 
Reagent Volume (μL) 
cDNA template 1 
dNTP (10 mM) 1 
FP (10 μM) 1 
RP (10 μM) 1 
Taq polymerase 0.2 
10× Taq polymerase buffer 2.5 
ddH2O 18.3 
Total Volume 25 
Table 2.11: PCR reaction mixure 
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Segment Cycle Temperature (°C) Time 
1 1 95 5 min 






3 1 72 5 min 
4 1 16 ∞ 
Table 2.12: PCR parameters 
2.5.4 Real-time PCR quantification analysis 
Real-time PCR was performed using the SYBR green I dye with the ABI Prism 7900 
sequence detector (Perkin-Elmer Applied Biosystems). Primers used in real-time PCR 
to amplify the fragments of mouse LHβ and FSHβ cDNA, with β-actin as an internal 
control, are listed in Table 2.13. The real-time PCR reactions were assembled as 
stated in Table 2.14. Cycling parameters are shown in Table 2.15. The comparative 
CT method was used to compare mRNA levels in the various samples which were 
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Primer Oligonucleotide sequence (5’-3’) 
LHβ F CAGTCTGCATCACCTTCACC 
LHβ R GCAGTACTCGGACCATGCTA 
FSHβ F  TGCACAGGACGTAGCTGTTT 
FSHβ R TGAGATGGTGATGTTGGTCA 
β-actin F CCTTCCTTCTTGGGTATGGA 
β-actin R ACGGATGTCAACGTCACACT 
Table 2.13: Primers used for real-time PCR analysis 
 
Reagent Volume 
2×SYBR green mix  
(Applied Biosystems) 
2.5 μL 
FP (10 nM) 1 μL 
RP (10 nM) 1 μL 
cDNA template 0.1 μg 
ddH2O Top up to final volume 
Total Volume 5 μL 
Table 2.14: Real-time PCR reaction mixure 
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Segment Cycle Temperature (°C) Time 
1 1 50 2 min 
2 1 95 10 min 




Table 2.15: Real-time PCR parameters 
2.6 Luciferase assay 
2.6.1 Promoter study 
LβT2 cells were plated in 96-well white plates. At 12-24 h after plating, expression 
vectors (50 ng for Pin1; 80 ng for SF-1 and Egr-1; 10 ng for Pitx1), the luciferase 
reporter vector (100 ng), and simian virus 40 (SV40) Renilla luciferase (2 ng) were 
transfected after equilibrating the total amount of DNA with pCS2+ empty vector or 
pWhitescript. The growth medium was removed 24-48 h post transfection and 20 µL 
1×PBS and 10 µL Dual-Glo Luciferase reagent (Promega) were added into each well. 
The cells were incubated for 10 min on a gently rotating platform at room temperature. 
Firefly luciferase reading was then measured using the Veritas Microplate 
luminometer (Turner Biosystems) accompanied by the Veritas Microplated 
Luminometer software (Turner Biosystems), according to the manufacturer’s 
instructions. After three rounds of readings, 10 µL Stop & Glo reagent (prepared 
freshly each time just before use by diluting Dual-Glo Stop & Glo Substrate with 
Dual-Glo Stop & Glo Buffer in 1:100; Promega) was added and after incubation for 
Materials and Methods 
71 
 
10 min on a rotating platform at room temperature, the Renilla level was measured 
similarly. Luciferase activity was calculated by normalizing Firefly luciferase reading 
to Renilla luciferase reading. Reporter gene activity was calculated as activity over 
basal levels (n-fold) generated from transfection of the luciferase reporter vector and 
pCS2+ empty vector or pWhitescript.  
2.6.2 Mammalian two-hybrid assay 
For the two-hybrid assays, COS-1 or LβT2 cells were plated in 96-well plates before 
transfection using 150 ng of the pM and pVP16 fusion constructs, 50 ng of the 
reporter gene (Luo et al.2005), and 2 ng of simian virus 40-Renilla luciferase as 
internal control. Cells were incubated for 24-48 h before harvest, and luciferase 
activity was measured as above. Reporter gene activity was calculated as activity over 
basal levels (n-fold) generated from transfection of the empty pM and pVP16 
constructs, after normalization with Renilla luciferase levels. Statistical analysis to 
determine protein interaction compared the additive effect of the pM fusion and pVP 
fusion expression vectors transfected separately with their effect when transfected 
together, as above. 
2.7 Statistical analysis 
Statistical analysis was performed using a simple unpaired t-test to determine means 
that were statistically different. Differences were considered significant when P<0.05. 
Synergy was determined by comparing the additive effects of expression vectors 
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transfected separately (using SE(x+y) = √[SE(x)2 + SE(y)2]) with the effect when 
both were transfected together, and was defined as a significantly (P<0.05) greater 
than additive effect.  
2.8 Chromatin immunoprecipitation (ChIP) 
LβT2 cells were grown to approximately 80% confluence in 100 mm dishes. The 
proteins were cross-linked to DNA with 1% formaldehyde (270 μL of 37% 
formaldehyde in 10 mL of culture medium) and incubated with gentle rotation for 10 
min at room temperature. Cross-linking was arrested by addition of 0.125 M glycine 
(1250 μL of 1 M glycine in 10 mL of growth medium) and incubated with gentle 
rotation for 5 min at room temperature. The cells were then rinsed three times with 
cold 1×PBS, collected and resuspended in 1000 µL ChIP lysis buffer, which was 
prepared as shown in Table 2.16. The samples were sonicated on ice with a 
MISONIX XL2020 sonifier to obtain DNA fragments of ~300 to 600 bp, at setting 3 
for 10 s for 6 times, with a 10 s rest in between, and then pelleted by centrifuging at 
13,000 rpm at 4 °C for 10 min. From the supernatant 50 µL was saved to quantify the 
input DNA in the samples and was stored at –20 °C until reverse cross-linking of the 
DNA together with that from the precipitated samples. Antibody [1 µg of anti-Pin1 
(Santa Cruz; sc-15340) or anti-HA (Santa Cruz; sc-805)] and 20 µL Protein A 
Sepharose CL-4B (GE Health) were added into 450 µL lysate and subsequently 
incubated overnight at 4 °C with gentle rotation. The antibody-bound complexes were 
washed extensively with each of the following buffers: low-salt wash buffer, high-salt 
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wash buffer, and LiCl wash buffer (see Table 2.16). This was followed by two washes 
with Tris-EDTA (see Table 2.16). The pellet was resuspended in 100 µL of elution 
buffer (see Table 2.16) by gentle flicking, and incubated at room temperature for 20 
min. The eluant was collected and the elution was repeated. Proteinase K (2 µL of 10 
mg/mL) was added to each input sample and these were incubated in 65 °C water bath 
for 4 h to reverse formaldehyde cross-links. The protein-bound DNA precipitated 
from the ChIP assay and input DNA were then purified with phenol-chloroform and 
dissolved in 25 µL H2O. Precipitated and input DNA served as template for 
promoter-specific PCR. Primers used to amplify the FSHβ or LHβ gene proximal 
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Table 2.16: Buffers used in ChIP analysis 
 
Primer Oligonucleotide sequence (5’-3’) 
Mouse LHβ promoter F  CAATCTGGGGGTTCAGCGAG 
Mouse LHβ promoter R CCTTGGGCACCTGGCTTTAT 
Mouse FSHβ promoter F CACAGCCCATAGGAACAAGA 
Mouse FSHβ promoter R CCAAAGCAGTCTAAATGCC 
Table 2.17: Primers used for amplification of the mouse LHβ and FSHβ 




50 mM Tris-Cl [pH 7.5], 1% NP-40, 0.5% Na deoxycholate, 
0.05% SDS, 1 mM EDTA, 150 mM NaCl, protease inhibitors 
low-salt wash 
buffer 
0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-Cl [pH 
8.0], 150 mM NaCl 
high-salt wash 
buffer 
0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-Cl [pH 
8.0], 500 mM NaCl 
LiCl wash 
buffer  
0.25 M LiCl, 1% NP-40, 1% Na deoxycholate, 1 mM EDTA, 10 
mM Tris-Cl [pH 8.0] 
Tris-EDTA 10 mM Tris-Cl [ pH 8.0], 1 mM EDTA 
elution buffer 0.1 M NaHCO3, 1% SDS 
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2.9 Immunoprecipitation (IP) 
For endogenous IP, LβT2 cells were washed with cold 1×PBS and lysed in RIPA 
buffer (20 mM Tris-Cl [pH 8.0], 125 mM NaCl, 0.5% NP-40, 5% glycerol, 20 mM 
NaF, 0.2 mM Na3VO4, 2 mM EDTA, and protease inhibitors) for 30 min. After 
centrifugation at 13,400×g for 40 min, 1 mg of total cell lysate was incubated with 1 
µg of antibody and 20 µl protein A or G Sepharose CL-4B (GE Health) overnight at 4 
°C with gentle rotation. The protein-antibody-bead complexes were washed four 
times with the lysis buffer. For Flag IP, 1 µg of Flag-tagged construct and 1 µg of 
HA-tagged construct were co-transfected into cells in 60 mm dishes. At 24 h after 
transfection, cells were washed with cold 1×PBS and lysed in RIPA buffer. After 
centrifugation at 13,400×g for 40 min, 100 µg of total cell lysate was incubated with 4 
µl of EZview Red ANTI-Flag M2 Affinity Gel (Sigma) for 2 h at 4 °C with gentle 
rotation. The protein-antibody-bead complexes were washed at least four times with 
the lysis buffer to reduce non-specific binding. SDS-PAGE coupled with Western blot 
analysis was used to resolve the complexes (See Section 2.12).  
2.10 In vivo ubiquitination assay  
Flag- or HA-tagged WT or mutant SF-1 and Myc- or HA-tagged WT or mutant 
(K48R and K63R) ubiquitin constructs were co-transfected into the cells grown in 60 
mm dish, and after 24 h, the cells were washed with cold 1×PBS and lysed for 30 min 
in RIPA buffer at 4 °C. After centrifugation at 13,400×g for 40 min at 4 °C, the 
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supernatants of the cell lysates were incubated with EZview Red ANTI-Flag M2 
Affinity Gel or mouse HA antibody-conjugated protein G beads for 2 h at 4 °C with 
gentle rotation, followed by four washes with lysis buffer, after which Western blot 
analysis was performed (See Section 2.12).  
The HA antibody was conjugated to the beads by incubating 1 µg of mouse HA 
antibody (Santa Cruz; sc-7392) with 20 µl protein G Sepharose CL-4B in RIPA buffer 
for 1 h at 4 °C, followed by extensive washes. 
2.11 In vivo SUMOylation assay 
Flag- or HA-tagged WT or mutant SF-1 and Myc-SUMO-1 constructs were 
co-transfected into the cells grown in 60 mm dish, and after 24 h, cells were washed 
with cold 1×PBS and lysed for 30 min in RIPA buffer containing 10 mM 
N-ethylmaleimide (NEM) at 4 °C. After centrifugation at 13,400×g for 40 min at 4 °C, 
the supernatants of the cell lysates were incubated with mouse HA 
antibody-conjugated protein G beads for 2 h at 4 °C with gentle rotation, followed by 
four washes with lysis buffer containing 10 mM NEM, after which Western blot 
analysis was performed (See Section 2.12).  
2.12 Western blot 
Cells were lysed in 1×lysis buffer, which was prepared as shown in Table 2.18. After 
centrifugation at 13,400×g for 40 min at 4 °C, the supernatant was collected and 
Materials and Methods 
77 
 
protein concentration was measured using Bradford Protein Assay reagent (Biorad) 
according to manufacturer’s instructions. For each sample, an equal volume of 2×SDS 
loading dye (Table 2.18) was added, and the mix was heated to 95 °C for 10 min 
before resolving on SDS-polyacrylamide gel (SDS PAGE) in SDS running buffer 
(Table 2.18) at 100 V for around 2 h at room temperature. The proteins were 
subsequently transferred to polyvinylidene fluoride (PVDF) membrane (Millipore) in 
transfer buffer (Table 2.18) at 100 V for 1 h at 4 °C. The membrane was then blocked 
with blocking buffer (Table 2.18) on a gently rotating platform for 1 h at room 
temperature, or overnight at 4 °C. After washing with 1×TBST (Table 2.18), the 
membrane was incubated with primary antibody diluted in dilution buffer (Table 2.18) 
for 2 h at room temperature, or overnight at 4 °C. Subsequently, washing was carried 
out three times, for 10 min each with 1×TBST on a gently rotating platform at room 
temperature. After washing with 1×TBST for 30 min, the membrane was then 
incubated with goat or bovine HRP-conjugated secondary antibody to mouse, rabbit 
or goat IgG (Santa Cruz) in dilution buffer for 1 h at room temperature, followed by 
extensive washes with 1×TBST as above. The immunoreactive proteins were detected 
using the Super Signal Pico West chemiluminescent system (Pierce Chemical), 
followed by exposure to FUJI medical X-Ray film (FUJIFILM). 
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Table 2.18: Buffers used in Western blot 
2.13 Fluorescence imaging 
LβT2 cells were seeded on ethanol-sterilized glass coverslips in 12-well plates, and 
after 24 h, transfected with pxj40-GFP empty vector, pxj40-GFP SF-1, or pxj40-GFP 
SF-1 K119R. Some of the cells were treated with 5 μM MG132 and/or 100 nM GnRH 
for 6 h, as indicated. The cells were fixed with cold-methanol at –20 °C for 10 min 
Buffer Components 
1×lysis buffer 50 mM Tris-Cl [pH 8.0], 100 mM NaCl, 1% SDS, 0.5% NP-40, 5% glycerol, 2 mM DTT, protease inhibitors 
2×SDS 
loading dye 
100 mM Tris-Cl [pH 6.8], 200 mM β-mercaptoethanol, 4% SDS, 
0.2% bromophenol blue, 20% glycerol 
Running 
buffer 
12.5 mM Tris-Cl [pH 7.4], 96 mM glycine, 1.7 mM SDS 
Transfer 
buffer 
58 mM Tris-Cl [pH 8.3], 40 mM glycine, 1.6 mM SDS, 20% 
methanol 
1×TBST 20 mM Tris-Cl [pH 7.4], 137 mM NaCl, 0.1% Tween-20 (add freshly) 
Blocking 
buffer 5% BSA in 1×TBST 
Dilution 
buffer 1% BSA in 1×TBST 
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and then permeabilized with 1×PBS containing 0.1% Triton X-100 for 20 min at 
room temperature. The fixed cells were washed twice with 1×PBS and then incubated 
with DAPI for 20 min, followed by washing with 1×PBS twice. The coverslips were 
mounted on glass slides using FluorSaveTM reagent (Calbiochem) and examined by 




CHAPTER 3   RESULTS 
3.1 Pin1 induces gonadotropin β subunit gene transcription 
3.1.1 Pin1 over-expression increases gonadotropin β subunit gene transcription 
In order to test whether Pin1 has a role in transcription of the gonadotropin β subunit 
genes, luciferase assays were carried out to assess the effect of Pin1 over-expression 
on their promoter activity in mouse gonadotrope LβT2 cells. LHβ or FSHβ gene 
promoter construct was transfected into LβT2 cells together with pCS2+ empty vector 
or pCS2+ Pin1 expression vector. At 24 h after transfection, these cells were either 
left untreated or treated with 100 nM GnRH for 4 h, and were analyzed for luciferase 
activity. As shown in Fig 3.1 Pin1 over-expression increased both the basal and 








Fig 3.1: Pin1 over-expression increases promoter activity of gonadotropin β subunit genes. 
LHβ or FSHβ promoter luciferase construct was transfected into LβT2 cells with pCS2+ empty vector 
or pCS2+ Pin1 expression vector, and some of the cells were exposed to 100 nM GnRH for 4 h before 
harvest. Luciferase assays were carried out and the levels of firefly luciferase were normalized to levels 
of Renilla; the results are expressed as normalized levels (n-fold) over those in control cells. Simple 
t-test compared mean values between groups with or without Pin1 over-expression, and was done 
separately for untreated and GnRH-treated groups; significantly different values (P<0.05) are 
designated with different letters, in upper case for untreated cells and in lower case for GnRH-treated 














The ability of Pin1 to increase transcription of the endogenous LHβ and FSHβ genes 
was next examined by real-time quantitative PCR (qPCR) using primers spanning an 
intron/exon border. As in the luciferase assays, Pin1 over-expression also increased 
the endogenous mRNA levels of LHβ and FSHβ in both untreated and GnRH treated 
cells (Fig 3.2A; over-expression of Pin1 was validated by Western blot as shown in 
Fig 3.2B).  
 
Fig 3.2: Pin1 over-expression increases endogenous mRNA levels of gonadotropin β subunit genes. 
(A) pCS2+ empty vector or pCS2+ Pin1 expression vector was transfected into LβT2 cells, and some 
of the cells were exposed to 100 nM GnRH for 4 h before harvest. Total mRNA was extracted and 
endogenous LHβ or FSHβ mRNA levels were measured by real-time PCR, using β-actin as an internal 
control, and are expressed as the levels (n-fold) over those in control cells. Simple t-test compared 
mean values between groups with or without Pin1 over-expression, and was done separately for 
untreated and GnRH-treated groups; significantly different values (P<0.05) are designated with 
different letters, in upper case for untreated cells and in lower case for GnRH-treated cells. Results are 
shown as mean ± SEM; n=3. (B) Western blot was carried out to determine the protein levels of Pin1 in 
LβT2 cells following its over-expression, with or without 100 nM GnRH treatment for 4 h; α-tubulin 




To confirm the role of Pin1 in increasing gonadotropin β subunit gene transcription, 
Pin1 WW domain mutant (Pin1 W34A) and PPIase domain mutant (Pin1 K63A) were 
over-expressed to test the requirement of the WW and PPIase domains. Real-time 
PCR showed that, in contrast to wild type (WT) Pin1, neither Pin1 W34A nor Pin1 
K63A was able to increase transcript levels of either the LHβ or the FSHβ genes, and 
that the W34A mutant even reduced LHβ transcript levels to below those of the 
control (Fig 3.3A; levels of over-expression were validated by Western blot as shown 









Fig 3.3: Wild type Pin1, but not its WW domain and PPIase domain mutants, increases 
endogenous mRNA levels of gonadotropin β subunit genes. 
(A) pCS2+ empty vector, pCS2+ Pin1, pCS2+ Pin1 W34A or pCS2+ Pin1 K63A expression vector 
was transfected into LβT2 cells. Total mRNA was extracted 24 h after transfection, and endogenous 
LHβ or FSHβ mRNA levels were measured by real-time PCR, using β-actin as an internal control, and 
are expressed as the levels (n-fold) over those in control cells. ANOVA followed by a Bonferroni t-test 
compared all means; significantly different values (P<0.05) are designated with different letters. 
Results are shown as mean ± SEM; n=3. (B) Western blot was carried out to determine the protein 
levels of Pin1 and its mutants in LβT2 cells following their over-expression; GAPDH is shown as a 








3.1.2 Pin1 knock-down decreases gonadotropin β subunit gene transcription 
The actual role of Pin1 in regulating expression of these genes was then verified by 
the knock-down of Pin1 expression with specific siRNA. Transfection of the Pin1 
targetting siRNA, but not the scrambled control siRNA, decreased the basal and, to a 
greater extent, the GnRH increased LHβ and FSHβ mRNA levels (Fig 3.4A; 
knock-down of Pin1 was validated by Western blot as shown in Fig 3.4B). This 
demonstrates that Pin1 plays a crucial role in GnRH-induced signaling pathways to 








Fig 3.4: Pin1 knock-down decreases endogenous mRNA levels of gonadotropin β subunit genes. 
(A) Control siRNA or Pin1 siRNA was transfected into LβT2 cells, and some of the cells were exposed 
to 100 nM GnRH for 4 h before harvest. Total mRNA was extracted and endogenous LHβ or FSHβ 
mRNA levels were measured by real-time PCR, using β-actin as an internal control, and are expressed 
as the levels (n-fold) over those in control cells. Simple t-test compared mean values between groups 
with or without Pin1 siRNA, and was done separately for untreated and GnRH treated groups; 
significantly different values (P<0.05) are designated with different letters, in upper case for untreated 
cells and in lower case for GnRH-treated cells. Results are shown as mean ± SEM; n=3. (B) Western 
blot was carried out to determine the protein levels of Pin1 in LβT2 cells following its knock-down, 









3.2 Pin1 is both transcriptionally and post-translationally regulated by GnRH 
3.2.1 GnRH increases Pin1 protein levels 
Previous studies by Wijeweera and Oh in our lab have demonstrated that GnRH 
upregulates Pin1 mRNA levels (Luo et al., 2010). Western blot on LβT2 whole cell 
lysate was performed to further study the effect of GnRH on Pin1 protein levels. Pin1 
protein was increased progressively with lengthening GnRH treatment, in a rapid but 
more moderate response than seen for calcineurin catalytic subunit A (CnA) and the 
immediate early protein ATF3, while GAPDH remained virtually unchanged (Fig 
3.5A). Fig 3.5B shows cell specificity of the GnRH effect on Pin1 by repeating the 2 
h GnRH treatment in gonadotrope (αT3-1 and LβT2) and non-gonadotrope (MEF and 






Fig 3.5: GnRH increases Pin1 protein levels. 
(A) Western blot was carried out to determine the protein levels of Pin1, CnA and ATF3 in LβT2 cells 
following 100 nM GnRH treatment for 0-4 h; GAPDH is shown as a loading control. (B) Western blot 
was carried out to determine the protein levels of Pin1 in MEF, COS-1, αT3-1 and LβT2 cells 










3.2.2 GnRH alters phosphorylation status of Pin1 
Since PKA and PKC which are known to be involved in the GnRH signaling pathway 
have been reported to phosphorylate Pin1 at Ser 16, Western blot was performed to 
examine whether GnRH also alters the phosphorylation status of Pin1. First, the 
specificity of the antibody to phosphorylated Pin1 at Ser 16 (p-Pin1) was confirmed 
by over-expressing GFP-Pin1 or GFP-Pin1 S16A in LβT2 cells treated with 100 nM 
GnRH for 0.5 h; immunoprecipitation of GFP-tagged proteins was followed by 
Western blot analysis using antibody to p-Pin1, Pin1 and GFP. Fig 3.6A shows that 
no immunoreactive band was seen for p-Pin1 antibody in either the input or GFP 
antibody immunoprecipitated sample in which GFP-Pin1 S16A was transfected. The 
p-Pin1 was easily detected after 15 min GnRH treatment and reached at a peak level 
after 30 min treatment, after which it gradually decreased (Fig 3.6B). In order to 
determine whether PKA and/or PKC is responsible for GnRH-induced Pin1 
phosphorylation, LβT2 cells were treated with PKC activator, PMA, or PKA activator, 
forskolin, for 1 h. The Western analysis showed that both treatments strongly induced 
p-Pin1 levels, indicating an involvement of PKA and/or PKC pathways in 





Fig 3.6: GnRH alters the phosphorylation status of Pin1. 
(A) Specificity of the antibody to p-Pin1 was confirmed by immunoprecipitating GFP-tagged proteins 
from LβT2 cell lysates after transfection of pEGFP empty vector, pEGFP Pin1, and pEGFP Pin1 S16A; 
Western blot was carried out to determine levels of p-Pin1, total Pin1 and GFP-tagged proteins in both 
the input and immunoprecipitated samples; GAPDH is shown as a loading control. (B) Western blot 
was carried out to determine the protein levels of p-Pin1 and Pin1 in LβT2 cells following 0 to 4 h 100 
nM GnRH treatment or exposure to 100 nM PMA or 1 μM forskolin for 1 h; GAPDH is shown as a 







Phosphorylation of Pin1 at Ser 16 has been reported to hinder its activity by 
preventing its interaction with the substrates and its nuclear localization (Lu et al., 
2002), and yet Pin1, although being temporarily phosphorylated by GnRH, appears 
required for LHβ and FSHβ gene transcription. It has been demonstrated that GnRH 
induces expression of the phosphatase calcineurin (Lim et al., 2007; Fig 3.5A), and 
initial studies by Oh (2009) in our lab have demonstrated that knock-down of 
calcineurin expression by specific siRNA, or inhibition of calcineurin activity by 
cyclosporin A increases p-Pin1 levels in LβT2 cells, indicating that GnRH-activated 
calcineurin might dephosphorylate p-Pin1 to allow its activity (Luo et al., 2010). To 
further confirm the actions of calcineurin on Pin1, co-immunoprecipitation was 
performed to examine whether calcineurin interacts with p-Pin1. The pCS2+ Pin1 was 
transfected into LβT2 cells and, 24 h after transfection, some of the cells were 
exposed to 100 nM GnRH for 0.5 h. The cells were lysed, and immunoprecipitated 
with anti-CnA antibody or IgG, followed by Western analysis using anti-p-Pin1, Pin1 
or CnA antibody. The p-Pin1 was co-precipitated by the CnA antibody, but not rabbit 
IgG, and the co-immunoprecipitation was more significant after GnRH treatment (Fig 
3.7). Taken together, these results clearly demonstrate a role for GnRH-activated 





Fig 3.7: p-Pin1 is associated with calcineurin catalytic subunit A. 
Cell lysates from LβT2 cells following Pin1 over-expression and exposure to 100 nM GnRH for 0 or 
0.5 h, as marked, were immunoprecipitated using antibody to CnA or normal rabbit IgG; Western blot 












3.3 Pin1 is present on the promoters of the LHβ and FSHβ genes and interacts 
with various gene-specific transcription factors 
3.3.1 Pin1 is present on the promoters of the LHβ and FSHβ genes  
In order to elucidate the mechanisms through which Pin1 activates LHβ and FSHβ 
gene transcription, chromatin immunoprecipitation was carried out to examine 
whether Pin1 is present on the promoters of these genes. After exposure to 100 nM 
GnRH for 0 or 4 h and cross-linking, the LβT2 cells were lysed and 
immunoprecipitation with Pin1 or HA antibody was performed to pull down the Pin1 
associated DNA. Association of Pin1 with the promoters of LHβ and FSHβ genes was 
detected in untreated LβT2 cells and after GnRH exposure for 4 h through PCR using 





Fig 3.8: Pin1 is present on the proximal promoters of the LHβ and FSHβ genes. 
(A) Schemes indicating the positions of PCR primers in the LHβ and FSHβ gene promoters. (B) ChIP 
was carried out using antibody to Pin1, or HA as control, in LβT2 cells with or without exposure to 100 
nM GnRH for 4 h, and PCR was performed to detect the endogenous mouse LHβ and FSHβ gene 









3.3.2 Pin1 interacts with various gene-specific transcription factors 
Since Pin1 itself is not a DNA binding protein, it was hypothesized that Pin1 is 
recruited to LHβ and FSHβ gene promoters through its interaction with specific 
transcription factors known to regulate expression of these genes. Therefore, 
co-immunoprecipitation assays were carried out using LβT2 cell lysates, and Pitx1, 
Egr-1 and β-catenin were detected in the precipitates using the Pin1 antibody but not 
in those using the control IgG (Fig 3.9A). Because the mobility of SF-1 is similar to 
that of the IgG heavy chain, co-immunoprecipitation using antibody to SF-1 for the 
precipitation was performed, and Pin1 was precipitated by the SF-1 antibody from 
both untreated and GnRH treated cell lysates, but not by the control IgG (Fig 3.9B).  
In order to confirm some of these interactions, mammalian two-hybrid assays were 
carried out in COS-1 cells using Pin1 fused to the Gal4 DBD (pM Pin1) and Pitx1, 
Egr-1, or SF-1 fused to VP16 AD (pVP Pitx1, pVP Egr-1, or pVP SF-1), together 
with Gal4-responsive luciferase reporter gene and pRL-SV40 Renilla as internal 
control. COS-1 cells were used to minimize the interference from endogenous 
expression of these transcription factors. Co-transfection of both pM Pin1, but not the 
empty pM vector, with pVP Pitx1, pVP Egr-1, or pVP SF-1 resulted in significant 
induction of the luciferase reporter gene activity (Figs 3.10 and 3.11A). This indicates 





Fig 3.9: Co-immunoprecipitation of Pin1 and various gonadotropin β subunit gene-specific 
transcription factors. 
(A) Cell lysates from LβT2 cells were immunoprecipitated using antibody to Pin1 or using normal IgG 
as control; Western blot was carried out to determine levels of β-catenin, Egr-1, Pitx1 and Pin1 in the 
input and precipitated samples. (B) Cell lysates from LβT2 cells following Pin1 over-expression and 
exposure to 100 nM GnRH, as marked, were immunoprecipitated using antibody to SF-1 or normal 
IgG; Western blot was carried out to determine levels of Pin1 in the input and precipitated samples.  
 
Fig 3.10: Interaction between Pin1 and various gonadotropin β subunit gene-specific transcription 
factors shown by mammalian two-hybrid assays. 
Mammalian two-hybrid assays were carried out in COS-1 cells using a Gal4-responsive reporter gene, 
and a Renilla luciferase as internal control, together with a Gal4 DBD empty vector (pM) or Gal4 
DBD-Pin1 fusion construct (pM Pin1) and VP16 AD empty vector (pVP) or VP16 AD fused to Pitx1 
(pVP Pitx1), Egr-1 (pVP Egr-1). Luciferase assays were carried out and the levels of firefly luciferase 
normalized to those of Renilla; results are expressed as the normalized levels (n-fold) over those in 
control cells, in which unfused Gal4 DBD and VP16 AD constructs were transfected together. 
Statistical analysis (t-test) to assess interaction, compared means for the groups transfected with both 
fusion constructs, with the combined effects of each fusion construct alone (*** P<0.001). Results are 




The two-hybrid assay was also carried out using an expression vector for SF-1 in 
which the only potential Pin1 binding site at serine 203 was mutated to alanine. The 
interaction of this mutated protein (SF-1 S203A) with Pin1 was markedly reduced in 
comparison to that of the WT SF-1 (Fig 3.11A). This reduced interaction of SF-1 
S203A with Pin1 was also demonstrated by co-immunoprecipitation assays in which 
the Flag-tagged SF-1 WT or S203A mutant protein was expressed in LβT2 cells and 
precipitated by Flag beads before immunoblotting with Pin1 antibody (Fig 3.11B).  
Mutagenesis of various Ser/Thr-Pro motifs in Pitx1 was also carried out to determine 
which residues are involved in the interaction with Pin1. Precipitation of the 
Flag-tagged Pin1 was performed after co-over-expression of Flag-Pin1 and 
HA-tagged Pitx1 WT or mutant proteins, followed by immunoblotting with antibody 
to the HA tag on the Pitx1 proteins. The binding of Flag-Pin1 with the Pitx1 mutants, 
HA-Pitx1 S207A, HA-Pitx1 S259A, or HA-Pitx1 T267A S270A, was clearly reduced 
in comparison with the wild type HA-Pitx1 (Fig 3.11C).  
These results indicate that Pin1 interacts directly with Pitx1, Egr-1 and SF-1, and 
demonstrate a crucial role for Ser 203 of SF-1 and for several residues of Pitx1 in 








Fig 3.11: Mutagenesis of Ser/Thr-Pro motifs in SF-1 and Pitx1 reduces the interaction between 
Pin1 and SF-1 or Pitx1. 
(A) Mammalian two-hybrid assays were carried out in COS-1 cells using a Gal4-responsive reporter 
gene, and a Renilla luciferase as internal control, together with a Gal4 DBD empty vector (pM) or Gal4 
DBD-Pin1 fusion construct (pM Pin1) and VP16 AD empty vector (pVP) or VP16 AD fused to SF-1 
(pVP SF-1), SF-1 S203A (pVP SF-1 S203A). Luciferase assays were carried out and the levels of 
firefly luciferase normalized to those of Renilla; results are expressed as the normalized levels (n-fold) 
over those in control cells, in which unfused Gal4 DBD and VP16 AD constructs were transfected 
together. Statistical analysis (t-test) to assess interaction, compared means for the groups transfected 
with both fusion constructs, with the combined effects of each fusion construct alone. In addition, the 
interactions of pM Pin1 with the WT and SF-1 S203A pVP fusion proteins were also compared (*** 
P<0.001). Results are shown as mean ± SEM; n=6. (B) Cell lysates from LβT2 cells following 
co-transfection of Pin1 and pxj40-Flag empty vector, Flag-SF-1 or Flag-SF-1 S203A were 
immunoprecipitated using anti-Flag M2 beads; Western blot was carried out to determine levels of 
Pin1, Flag-SF-1 and Flag-SF-1 S203A in the input and precipitated samples. (C) Cell lysates from 
LβT2 cells following co-transfection of Flag-Pin1 and pxj40-HA empty vector, HA-Pitx1 WT or 
mutant constructs were immunoprecipitated using anti-Flag M2 beads; Western blot was carried out to 




3.4 Pin1 increases transcriptional activity of SF-1, Pitx1 and Egr-1 
In order to examine whether the interaction between Pin1 and these transcription 
factors plays a functional role in transcription of the gonadotropin β subunit genes, the 
effects of Pin1 on transactivation of these genes by Pitx1, Egr-1 or SF-1 were 
examined using luciferase assays. LHβ or FSHβ promoter luciferase construct was 
transfected into LβT2 cells alone or together with the expression vectors for Pin1 
and/or the transcription factors, and luciferase assays were carried out to assess 
whether they acted synergistically. The results showed that Pin1 and SF-1 had a 
synergistic effect on the LHβ but not on the FSHβ gene promoter (Fig 3.12), while 
Pin1 and Pitx1 had a synergistic effect on the FSHβ but not the LHβ gene promoter 
(Fig 3.13). Egr1, which targets only the LHβ gene, also had a synergistic effect with 








Fig 3.12: Pin1 and SF-1 have a synergistic effect on the LHβ but not on the FSHβ gene promoter.  
LHβ or FSHβ promoter luciferase construct was transfected into LβT2 cells alone or together with Pin1 
and/or SF-1 expression vectors. After 24 h, cells were harvested. Luciferase assays were carried out 
and the levels of firefly luciferase were normalized to levels of Renilla; the results are expressed as 
normalized levels (n-fold) over those in control cells. Simple t-test compared mean values between 
groups transfected with Pin1 and SF-1 expression vector, with the combined effects of each construct 
alone, where ***, P<0.001 and NS, not synergistic. Results are shown as mean ± SEM; n=6.  
 
Fig 3.13: Pin1 and Pitx1 have a synergistic effect on the FSHβ but not on the LHβ gene promoter. 
LHβ or FSHβ promoter luciferase construct was transfected into LβT2 cells alone or together with Pin1 
and/or Pitx1 expression vectors. After 24 h, cells were harvested. Luciferase assays were carried out 
and the levels of firefly luciferase were normalized to levels of Renilla; the results are expressed as 
normalized levels (n-fold) over those in control cells. Simple t-test compared mean values between 
groups transfected with Pin1 and Pitx1 expression vector, with the combined effects of each construct 






Fig 3.14: Pin1 and Egr-1 have a synergistic effect on the LHβ gene promoter.  
LHβ promoter luciferase construct was transfected into LβT2 cells alone or together with Pin1 and/or 
Egr-1 expression vectors. After 24 h, cells were harvested. Luciferase assays were carried out and the 
levels of firefly luciferase were normalized to levels of Renilla; the results are expressed as normalized 
levels (n-fold) over those in control cells. Simple t-test compared mean values between groups 
transfected with Pin1 and Egr-1 expression vector, with the combined effects of each construct alone, 











3.5 Effects of Pin1 on the levels of these transcription factors 
Since Pin1 binds directly to Pitx1, Egr-1 and SF-1 and enhances their transactivation, 
it was speculated that Pin1 might affect the stability of these transcription factors. To 
test this hypothesis, Pin1 expression vector was transfected into LβT2 cells and the 
cells were harvested 0, 24, 36 and 48 h after transfection. Western blot showed that 
Pin1 over-expression led to an increase in Pitx1 but a decrease in SF-1 levels, while 
Egr-1 and GAPDH protein levels remained unchanged over the 48 h (Fig 3.15A). 
Some of this could be due to Pin1 regulating transcription of these factors, as RT-PCR 
after over-expression of Pin1 showed a clear increase in Pitx1 mRNA levels, while 
SF-1 mRNA levels decreased marginally (Fig 3.15B). In order to investigate the 
post-transcriptional effects of Pin1 on these proteins, constructs encoding HA-tagged 
Pitx-1 or SF-1 were transfected with or without Pin1 expression vector. Western blot 
of the HA-tagged proteins showed the same trend of an increase in Pitx1 and a 
decrease in SF-1 protein levels, both of which were more pronounced when more of 











Fig 3.15: Effects of Pin1 on the levels of these transcription factors.  
(A) Western blot was carried out to determine the protein levels of Egr-1, SF-1, Pitx1 and Pin1 in LβT2 
cells transfected with pCS2+ empty vector or pCS2+ Pin1 expression vector for 0, 24, 36 and 48 h; 
GAPDH is shown as a loading control. (B) RT-PCR analysis of SF-1 and Pitx1 mRNA levels was 
carried out in LβT2 cells transfected with pCS2+ empty vector or pCS2+ Pin1 expression vector; 
β-actin was used as an internal control. All transfections were carried out in duplicate. (C) Western blot 
was carried out to detect the protein levels of HA-Pitx1 and HA-SF-1 in LβT2 cells transfected with 
pCS2+ empty vector or different amount of pCS2+ Pin1 expression vector; GAPDH is shown as a 






3.6 Regulation of SF-1 ubiquitination  
3.6.1 Ser 203 is required for SF-1 ubiquitination 
To investigate the molecular mechanism underlying the Pin1-induced decrease in 
SF-1 protein levels, in vivo ubiquitination assays were carried out to examine whether 
Pin1 is involved in ubiquitination of SF-1. Ubiquitination of WT HA-SF-1 and 
HA-SF-1 S203A, in which the only Pin1 binding site was mutated, was analyzed by 
immunoprecipitation of the tagged protein followed by Western blot using an 
antibody against ubiquitin. In the input and HA-immunoprecipitated samples a 
mono-ubiquitinated form of SF-1 was evident (between the 50 and 75 kDa markers) 
following transfection of the WT but not the S203A mutant construct, while the SF-1 
ubiquitination was reduced to an undetectable level when serine 203 in SF-1 was 
mutated to alanine (Fig 3.16A).  
Similarly, the SF-1 WT or S203A construct was transfected with an expression vector 
for Myc-tagged ubiquitin, and immunoprecipitation was carried out using rabbit 
antibdoy to the Myc tag. The input and precipitated proteins were blotted with mouse 
antibody to HA. Again, in this reciprocal immunoprecipitation the mono- and 








Fig 3.16: Ubiquitination of SF-1 requires Ser 203.  
(A) Cell lysates from LβT2 cells following transfection of HA-SF-1 or HA-SF-1 S203A expression 
vector were immunoprecipitated using mouse anti-HA antibody; the input and precipitated samples 
were analyzed by Western blot using rabbit anti-HA and mouse anti-ubiquitin (Ub) antibodies. (B) Cell 
lysates from LβT2 cells following co-transfection of Myc-ubiquitin (Myc-Ub) and HA-SF-1 or 
HA-SF-1 S203A expression vector were immunoprecipitated using mouse anti-Myc antibody, and 
input and precipitated samples were analyzed by Western blot using mouse anti-HA antibody. The 
mono-ubiquitinated SF-1 is marked with arrows on the left. An apparently non-specific 





3.6.2 Pin1 is required for SF-1 ubiquitination 
In order to assess the role of Pin1 in the SF-1 ubiquitination, in vivo ubiquitination 
assays were carried out in LβT2 cells after over-expression of Flag-tagged SF-1, with 
control siRNA or Pin1 specific siRNA transfection. SF-1 was clearly 
poly-ubiquitinated in LβT2 control cells, but in the Pin1 knock-down cells SF-1 
ubiquitination was reduced (Fig 3.17A). To confirm this, further studies were carried 
out in stably transfected HEK 293T control or Pin1 knock-down cells (expressing 
Pin1 but at lower levels) (Fig 3.17B) after over-expression of HA-tagged WT SF-1 or 
the S203A mutant. From the blot of the immunoprecipitated samples with ubiquitin 
antibody (Fig 3.17B, bottom panel on the right), it is evident that SF-1 was also 
poly-ubiquitinated in HEK 293T control cells, but in the Pin1 knock-down cells, SF-1 
ubiquitination was clearly reduced, while in neither cell line did the SF-1 S203A 
appear to be ubiquitinated. The apparently mono-ubiquitinated band again can be seen 
in the input and HA-immunoprecipitated samples when the WT SF-1 was transfected, 
but it was barely detectable in the Pin1 knock-down cells (Fig 3.17B, top left and top 
right panels). These results indicate that Pin1 increases SF-1 ubiquitination through a 









Fig 3.17: Ubiquitination of SF-1 requires Pin1. 
(A) Cell lysates from LβT2 cells transfected with Flag-SF-1, 12 h after transfection of control or Pin1 
siRNA, were immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were 
analyzed by Western blot using antibodies to Flag, SF-1, Ub, and Pin1, with GAPDH as a loading 
control. (B) Cell lysates from 293T control (293T Ctrl) and Pin1 siRNA (293T Pin1 KD) cells 
transfected with HA-SF-1 or HA-SF-1 S203A expression vectors were immunoprecipitated using 
mouse anti-HA antibody; the input and precipitated samples were analyzed by Western blot using 
antibodies to HA, Ub, and Pin1, with α-tubulin (Tub) as a loading control. Longer exposure time also 
showed the ubiquitinated SF-1 in HA antibody blotting. The mono-ubiquitinated SF-1 is marked with 




3.7 GnRH treatment stimulates SF-1 ubiquitination 
It has already been shown that SF-1 is ubiquitinated in untreated LβT2 cells. Next, 
GnRH treatment was performed to examine the effect of GnRH on SF-1 
ubiquitination. Fig 3.18 shows that ubiquitinated SF-1 was detectable in untreated 
LβT2 cells and was greatly enhanced after GnRH treatment for 6 h. 
 
Fig 3.18: GnRH treatment increases ubiquitination of SF-1.  
Cell lysates from LβT2 cells following transfection of Flag-SF-1 expression vector or pxj40-Flag 
empty vector and exposure to 100 nM GnRH for 0 or 6 h, as marked, were immunoprecipitated using 
anti-Flag M2 beads; the precipitated samples were analyzed by Western blot using rabbit anti-Flag and 
mouse anti-ubiquitin antibodies. Longer exposure time also showed the ubiquitinated SF-1 in Flag 







The fact that GnRH induces SF-1 ubiquitination led to the speculation that 
phosphorylation of SF-1 at Ser 203 by GnRH-activated ERK 1/2 might be the cause 
of the increase in SF-1 ubiquitination. GnRH-induced activation of ERK within 30 
min, and an effect was still seen after 2 and 4 h, but treatment with the specific 
inhibitor, U0126, virtually abolished this GnRH-induced effect (Fig 3.19A). Next, the 
effect of this U0126-induced ERK inhibition on SF-1 ubiquitination was examined by 
in vivo ubiquitination assay. In unstimulated cells, U0126 treatment did not change 
the levels of poly-Ub SF-1, however, in GnRH treated cells U0126 treatment reduced 
SF-1 poly-ubiquitination to a modest level as compared to that in cells treated with 
GnRH alone (Fig 3.19B). These results suggest that phosphorylation of SF-1 at Ser 













Fig 3.19: U0126 treatment inhibits GnRH-induced SF-1 ubiquitination. 
(A) Western blot was carried out to determine the protein levels of phosphorylated ERK (p-ERK) in 
LβT2 cells after exposure to 100 nM GnRH for 0 to 4 h and/or 1 µM U0126, as indicated; total ERK is 
shown as a loading control. (B) Cell lysates from LβT2 cells following transfection of Flag-SF-1 or 
Flag-SF-1 S203A expression vector and exposure to 100 nM GnRH and/or 1 µM U0126 for 0 or 4 h, as 
marked, were immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were 
analyzed by Western blot using rabbit anti-Flag and mouse anti-ubiquitin antibodies, with GAPDH as a 





It has been reported that SF-1 is constitutively phosphorylated under normal cell 
culture condition without any treatment (Hammer et al., 1999), and CDK7, a 
component of the general transcription factor IIH (TFIIH), has been shown recently to 
phosphorylate SF-1 at Ser 203 (Lewis et al., 2008). Therefore, it was hypothesized 
that SF-1 ubiquitination is also affected by CDK7- mediated phosphorylation of SF-1. 
Since activation of CDK7 is dependent on its phosphorylation at Thr 170, Western 
blot was carried out to determine the level of phosphorylated CDK7 in LβT2 cells 
treated with GnRH for different times. Phosphorylated CDK7 at Thr 170 was detected 
in unstimulated cells, and the level was not obviously affected by GnRH treatment 
(Fig 3.20A). Subsequently, in vivo ubiquitination assays of WT and S203A SF-1 were 
performed in the absence or presence of the CDK7 inhibitor, Roscovitine (ROS), with 
or without GnRH. The treatment with ROS clearly inhibited SF-1 ubiquitination in 












Fig 3.20: Roscovitine (ROS) treatment inhibits SF-1 ubiquitination. 
(A) Western blot was carried out to determine the protein levels of phosphorylated CDK7 on Thr 170 
(p-CDK7 T170) in LβT2 cells after exposure to 100 nM GnRH for 0 to 6 h, as indicated; α-tubulin 
(Tub) is shown as a loading control. (B) Cell lysates from LβT2 cells following transfection of 
Flag-SF-1 or Flag-SF-1 S203A expression vector and exposure to 100 nM GnRH and/or 15 µM ROS 
for 0 or 4 h, as marked, were immunoprecipitated using anti-Flag M2 beads; the input and precipitated 
samples were analyzed by Western blot using rabbit anti-Flag and mouse anti-ubiquitin antibodies, 







To exclude the possible indirect effects caused by ROS-induced delay in cell cycle 
progression, HA-tagged WT or dominant negative (DN) CDK7 were over-expressed 
to confirm the specificity of the CDK7 effect on SF-1 ubiquitination. Over-expression 
of the WT protein clearly increased levels of SF-1 ubiquitination, while the DN form 
failed to do so and caused a minor decrease compared to levels in cells transfected 
only with Flag-tagged SF-1 expression vector (Fig 3.21).  
Taken together, these results demonstrate that ubiquitination of SF-1 is Ser 203 
phosphorylation dependent, and that GnRH treatment increases SF-1 ubiquitination at 
least partially via the activation of ERK1/2, although in unstimulated conditions 







Fig 3.21: Dominant negative mutant CDK7 inhibits SF-1 ubiquitination. 
Cell lysates from LβT2 cells following transfection of Flag-SF-1 alone or together with wild type 
HA-CDK7 or dominant negative HA-CDK7 D155A expression vector, as marked, were 
immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were analyzed by 
Western blot using anti-CDK7, anti-Flag, rabbit anti-SF-1 and mouse anti-ubiquitin antibodies, with 










3.8 SF-1 can be ubiquitinated or SUMOylated at Lys 119 
Considering that SF-1 is SUMOylated at both Lys 119 and Lys 194, and that a similar 
conjugation mechanism is shared by SUMOylation and ubiquitination, in vivo 
ubiquitination assays were performed to examine whether SF-1 is ubiquitinated at Lys 
119 and/or Lys 194. The ubiquitination of WT HA-SF-1, and a series of mutants: 
HA-SF-1 S203A, HA-SF-1 K119R, HA-SF-1 K194R, and HA-SF-1 K119R & 
K194R (2KR) were examined in LβT2 cells. The in vivo ubiquitination assay showed 
that both WT HA-SF-1 and HA-SF-1 K194R are efficiently poly-ubiquitinated in 
LβT2 cells, while mutation of Lys 119 to Arg or mutation of Ser 203 to Ala prevented 
SF-1 from being poly-ubiquitinated (Fig 3.22). Thus, the ubiquitination site in SF-1 is 
Lys 119.  
 
Fig 3.22: SF-1 is ubiquitinated at Lys 119. 
Cell lysates from LβT2 cells following transfection of Myc-tagged ubiquitin and WT HA-SF-1, 
HA-SF-1 S203A, K119R, K194R, 2KR (K119R & K194R), or pxj40-HA empty vector, as marked, 
were immunoprecipitated using mouse anti-HA Ab; the input and precipitated samples were analyzed 
by Western blot using rabbit or mouse anti-Myc and anti-HA antibodies, with α-tubulin (Tub) as a 




Since it has been shown that ubiquitination of SF-1 is dependent on phosphorylation 
of SF-1 at Ser 203, and that both ubiquitin and SUMO target the same lysine residue 
in SF-1, it was speculated that SUMOylation of SF-1 might be also affected by its 
phosphorylation. Using an in vivo SUMOylation assay in which wild type HA-SF-1 
and the same SF-1 mutant constructs used above were transfected, it was found that 
SUMOylation of SF-1 was not affected by mutation of Ser 203 to Ala (Fig 3.23). 
However, SUMOylation at Lys 119 does not occur when Lys 194 is mutated to Arg 
(Fig 3.23), indicating that SUMOylation at Lys 194 is a prerequisite of Lys 119 
SUMOylation.  
 
Fig 3.23: SF-1 is SUMOylated at Lys 119 and Lys 194. 
LβT2 cells were transfected with Myc-tagged SUMO-1 and WT HA-SF-1, HA-SF-1 S203A, K119R, 
K194R, 2KR (K119R & K194R), or pxj40-HA empty vector, as marked. After 24 h, the cells were 
lysed in NEM-RIPA buffer and lysates were immunoprecipitated with mouse anti-HA antibody; the 
input and precipitated samples were analyzed by Western blot using anti-Myc and rabbit or mouse 
anti-HA antibodies, with α-tubulin (Tub) as a loading control. It should be noted that the SUMOylated 
proteins are expected to run more slowly than predicted by their size, and the labelled proteins 




Together, these results show that both ubiquitination and SUMOylation of SF-1 can 
occur at the same site, Lys 119, and that this ubiquitination is Ser 203 phosphorylation 
dependent while SUMOylation of Lys 119 is not, but requires Lys 194 SUMOylation. 
3.9 Poly-ubiquitin chains on SF-1 are assembled through either Lys 48 or Lys 63 
of ubiquitin 
As reviewed in Section 1.6.1, poly-ubiquitin chains linked through Lys 48 in ubiquitin 
reportedly target a protein for proteasomal degradation, while attachment through Lys 
63 is thought to indicate non-proteolytic functions including transcriptional regulation 
and immune response (Pickart and Fushman, 2004; Sun and Chen, 2004). Therefore, 
in vivo ubiquitination assays were carried out to examine whether Lys 48 or Lys 63 in 
ubiquitin is involved in the formation of poly-ubiquitin chains on SF-1. Lysate of 
LβT2 cells transfected with Flag-SF-1 and HA-Ub K48R or HA-Ub K63R were 
precipitated by Flag beads, and the precipitates were subject to Western analysis by 
HA antibody. The results revealed that mutation of either residue failed to prevent 
SF-1 ubiquitination, however mutation of Lys 63 reduced poly-ubiquitin chain 
formation on SF-1 more than mutation of Lys 48 (Fig 3.24). This demonstrates that 
SF-1 can be ubiquitinated via Lys 48- and Lys 63-linked poly-ubiquitin chains, and 
indicates the possibility that this modification is likely involved in several 






Fig 3.24: SF-1 is ubiquitinated via Lys 48- and Lys 63-linked poly-ubiquitin chains. 
Cell lysates from LβT2 cells following transfection of HA-Ub K48R or HA-Ub K63R alone or together 
with Flag-SF-1 expression vector, as marked, were immunoprecipitated using anti-Flag M2 beads; the 
input and precipitated samples were analyzed by Western blot using rabbit or mouse anti-Flag and 











3.10 SF-1 ubiquitination, but not SUMOylation, facilitates its interaction with 
Pitx1 
Previous studies by others have already shown that SUMOylation of SF-1 suppresses 
transcription activity of SF-1 by inhibiting the interaction between SF-1 and cofactors, 
and that phosphorylation of SF-1 at Ser 203 is critical for the recruitment of cofactors 
(Hammer et al., 1999; Campbell et al., 2008; Yang et al., 2009). Since ubiquitination 
and SUMOylation of SF-1 can occur at the same site, Lys 119, and poly-ubiquitin 
chains targeting on SF-1 can be linked in ubiquitin through either Lys 48 or Lys 63, 
next it was asked whether the Ser 203 phosphorylation-dependent ubiquitination of 
SF-1 promotes gonadotropin β subunit gene transcription by increasing SF-1–Pitx1 
interactions, in a way that SUMOylation does not, and whether this is 
proteosome-dependent. Initially, Western analysis was performed using 
Flag-immunoprecipitated samples from LβT2 cell lysates after transfection with 
Flag-SF-1 and HA-Pitx1 (Fig 3.25A), or on the endogenous proteins (Fig 3.25B), in 
the absence or presence of MG132 for 6 h. In both cases, treatment with the 
proteasome inhibitor, MG132, increased the binding between SF-1 and Pitx1 (Fig 
3.25A and B). Both SF-1 and Pitx1 are poly-ubiquitinated in LβT2 cells and it was 
found that treatment of cells with MG132 substantially increased the levels of both 
poly-ubiquitinated proteins (Fig 3.25C). Therefore, to exclude the possibility that their 
enhanced binding results from an effect of MG132 on Pitx1, LβT2 cells were 
transfected with Flag-SF-1 and Myc-Ub, or Flag-SF-1 and pxj40-Myc empty vector. 




lysates containing HA-Pitx1. Western blot showed that Myc-Ub over-expression led 
to an increase in Flag-SF-1 poly-ubiquitination, while the Flag-SF-1-Ub-Myc bound 
more HA-Pitx1 than did the Flag-SF-1 when transfected alone (Fig 3.25D). Similarly, 
Myc-SUMO-1 was transfected with Flag-SF-1, which increased levels of 
SUMOylated Flag-SF-1, but led to a decrease in the interaction between Flag-SF-1 
and HA-Pitx1 (Fig 3.25D). Together, these results suggest that ubiquitination of SF-1 
increases, and SUMOylation decreases, the binding between SF-1 and Pitx1, and that 
the transcriptional activity of SF-1 results from the balance between these two 













Fig 3.25: SF-1 ubiquitination facilitates its interaction with Pitx1. 
(A) Cell lysates from LβT2 cells following transfection of HA-Pitx1 alone or together with Flag-SF-1 
expression vectors, and exposure to 5 µM MG132 for 0 or 6 h, as marked, were immunoprecipitated 
using anti-Flag M2 beads; the input and precipitated samples were analyzed by Western blot using 
rabbit or mouse anti-Flag and anti-HA antibodies. (B) Cell lysates from LβT2 cells following exposure 
to 5 µM MG132 for 0 or 6 h, as marked, were immunoprecipitated with anti-SF-1 antibody or normal 
IgG; the input and precipitated samples were analyzed by Western blot using anti-SF-1 and anti-Pitx1 
antibodies. (C) Cell lysates from LβT2 cells following exposure to 5 µM MG132 for 0 or 6 h, as 
marked, were immunoprecipitated with anti-SF-1 antibody, anti-Pitx1 antibody, or normal IgG; the 
precipitated samples were analyzed by Western blot using anti-Ub antibody. (D) LβT2 cells were 
co-transfected with Flag-SF-1or pxj40-Flag empty vector and Myc-Ub, Myc-SUMO-1 or pxj40-Myc 
empty vector, as indicated. After 24 h, the cells were lysed in NEM-RIPA buffer and lysates were 
immunoprecipitated with anti-Flag M2 beads. After extensive washes, the Flag beads were incubated 
with HA-Pitx1-containing cell lysates for 3 h. The precipitated samples were analyzed by Western blot 




3.11 Ubiquitination of SF-1 leads to its nuclear export 
Finally, in order to test whether the GnRH-induced ubiquitination of SF-1 causes a 
change in its localization, the localization of GFP-SF-1 and GFP-SF-1 K119R was 
examined in LβT2 cells treated with GnRH and/or MG132. In non-treated cells, 
GFP-SF-1 was exclusively localized in the nucleus; however, exposure to GnRH 
and/or MG132 resulted in both nuclear and cytoplasmic distribution of GFP-SF-1. 
GFP-SF-1 K119R was localized only in the nucleus, even after GnRH and/or MG132 
treatment (Fig 3.26). Therefore, it is speculated that nuclear export of SF-1 by GnRH 
















































































































































































3.12 Pin1 targets SF-1 to increase its interaction with Pitx1  
It has been demonstrated that ubiquitination of SF-1 increases the binding between 
SF-1 and Pitx1, and that Pin1 upregulates this ubiquitination, indicating that Pin1 
likely increases interaction of the two transcription factors. To test this possibility, 
MEF WT and Pin1 –/– cells were transfected with Flag-SF-1 and HA-Pitx1 or 
HA-Egr-1 before carrying out co-immunoprecipitations using the cell lysates. 
Western blot showed that the interaction between SF-1 and Pitx1 was markedly 
reduced in MEF Pin1 –/– cells compared to that in MEF WT cells (Fig 3.27A). This 
contrasted with the interaction of SF-1 with Egr-1 which did not differ between the 
two cell lines (Fig 3.27B), while the interaction of Pitx-1 with Egr-1 was only 









Fig 3.27: Interaction between SF-1 and Pitx1 decreases in the absence of Pin1. 
(A) Cell lysates from MEF WT and MEF Pin1 –/– cells following transfection of Flag-SF-1 and 
HA-Pitx1 were immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were 
analyzed by Western blot using rabbit or mouse anti-Flag, anti-HA, and anti-Pin1 antibodies. (B) Cell 
lysates from MEF WT and MEF Pin1 –/– cells following transfection of Flag-SF-1 and HA-Egr-1 were 
immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were analyzed by 
Western blot using rabbit or mouse anti-Flag, anti-HA, and anti-Pin1 antibodies. (C) Cell lysates from 
MEF WT and MEF Pin1 –/– cells following transfection of Flag-Pitx1 and HA-Egr-1 were 
immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were analyzed by 










In order to confirm that the decreased interaction between SF-1 and Pitx1, or Pitx1 
and Egr-1 in MEF Pin1 –/– cells is the direct effect of deficiency of Pin1 in these cells, 
MEF Pin1 –/– cells, which were reconstituted with wild type Pin1, Pin1 W34A, or 
Pin1 K63A mutant, were transfected with Flag-SF-1 and HA-Pitx1, or Flag-Pitx1 and 
HA-Egr-1, followed by co-immunoprecipitations using the cell lysates. Western blot 
showed that the reduced interaction of Pitx1 with SF-1 or Egr-1 was rescued by 
exogenous Pin1, but not to the same degree by the WW or PPIase mutants (Fig 3.28A 















Fig 3.28: Exogenous Pin1 rescues the interaction between SF-1 and Pitx1 in MEF Pin1 –/– cells. 
(A) Cell lysates from MEF Pin1 –/– cells following transfection of Flag-SF-1 and HA-Pitx1 or 
pxj40-HA empty vector, together with pCS2+ empty vector, pCS2+ Pin1, pCS2+ Pin1 W34A, or 
pCS2+ Pin1 K63A, as marked, were immunoprecipitated using anti-Flag M2 beads; the input and 
precipitated samples were analyzed by Western blot using rabbit or mouse anti-Flag, anti-HA, and 
anti-Pin1 antibodies, with GAPDH as a loading control. (B) Cell lysates from MEF Pin1 –/– cells 
following transfection of Flag-Pitx1 and HA-Egr-1 or pxj40-HA empty vector, together with pCS2+ 
empty vector, pCS2+ Pin1, pCS2+ Pin1 W34A, or pCS2+ Pin1 K63A, as marked, were 
immunoprecipitated using anti-Flag M2 beads; the input and precipitated samples were analyzed by 
Western blot using rabbit or mouse anti-Flag, anti-HA, and anti-Pin1 antibodies, with GAPDH as a 







In order to examine which factor targeted by Pin1 is responsible for the increase in 
Pitx-1-SF-1 interaction, co-immunoprecipitations and Western blot were performed to 
examine the binding between Flag-SF-1 and wild type HA-Pitx1 or mutant HA-Pitx1, 
in which various Pin1 binding sites were mutated. Although these residues were 
shown to bind Pin1 (Fig 3.11C), mutation in Pitx1 of Ser 207, Ser 259, or Thr 267 and 
Ser 270 did not lead to significant alteration of its interaction with SF-1 (Fig 3.29A). 
However, SF-1 mutation of Ser 203 to Ala markedly reduced the interaction with 
Pitx1 (Fig 3.29B). These results indicate that Pin1 increases the interaction of SF-1 
with Pitx1 through targeting SF-1.  
 
Fig 3.29: Mutation of Pin1 binding site in SF-1 reduces its interaction with Pitx1. 
(A) Cell lysates from LβT2 cells following co-transfection of Flag-SF-1 and pxj40-HA empty vector, 
HA-Pitx1 WT or mutant constructs were immunoprecipitated using anti-Flag M2 beads; the input and 
precipitated samples were analyzed by Western blot using rabbit or mouse anti-Flag and anti-HA 
antibodies. (B) Cell lysates from LβT2 cells following co-transfection of HA-Pitx1 and Flag-SF-1 or 
Flag-SF-1 S203A were immunoprecipitated using anti-Flag M2 beads; the input and precipitated 






3.13 Pin1 interacts with ATF3  
While searching for gonadotropin gene-specific transcription factors regulated by 
Pin1, co-immunoprecipitation assays revealed that Pin1 can also bind to ATF3 (Fig 
3.30A and B), which was shown previously to mediate activation of human αGSU 
promoter by GnRH (Xie et al., 2005). In order to confirm the interaction, mammalian 
two-hybrid assays were performed in COS-1 cells using pM Pin1 and pVP ATF3, 
together with Gal4-responsive luciferase reporter gene and pRL-SV40 Renilla as 
internal control. Co-transfection of both pM Pin1, but not the empty pM vector, with 
pVP ATF3, resulted in significant induction of the luciferase reporter gene activity 













Fig 3.30: Interaction between Pin1 and ATF3. 
(A) Cell lysates from LβT2 cells were immunoprecipitated using antibody to Pin1 or using normal IgG 
as control; Western blot was carried out to determine levels of ATF3 and Pin1 in the input and 
precipitated samples. (B) Cell lysates from COS-1 cells co-transfected with Pin1 and ATF3 expression 
vectors were immunoprecipitated using antibody to ATF3 or using normal IgG as control; Western blot 
was carried out to determine levels of ATF3 and Pin1 in the input and precipitated samples. (C) 
Mammalian two-hybrid assays were carried out in COS-1 cells using a Gal4-responsive reporter gene, 
and a Renilla luciferase as internal control, together with a Gal4 DBD empty vector (pM) or Gal4 
DBD-Pin1 fusion construct (pM Pin1) and VP16 AD empty vector (pVP) or VP16 AD fused to ATF3 
(pVP ATF3). Luciferase assays were carried out and the levels of firefly luciferase normalized to those 
of Renilla; results are expressed as the normalized levels (n-fold) over those in control cells, in which 
unfused Gal4 DBD and VP16 AD constructs were transfected together. Statistical analysis (t-test) to 
assess interaction, compared means for the groups transfected with both fusion constructs, with the 








3.14 Pin1 increases the stability of ATF3  
Since Pin1 interacts with ATF3, Western blot was carried out to examine whether 
Pin1 over-expression affects the level of ATF3 in gonadotropes. ATF3 protein level 
was seen to increase after over-expressing Pin1 (Fig 3.31A); however, its mRNA 
level was not obviously affected by Pin1 (Fig 3.31B). Therefore, it was speculated 
that Pin1 might be able to stabilize the ATF3 protein. In order to test this hypothesize, 
the half life of HA-tagged ATF3 in both MEF WT and Pin1 –/– cells was compared 
by exposing those cells to the protein synthesis inhibitor cycloheximide for various 
times. HA-ATF3 in Pin1 deficient MEF cells was clearly less stable than in MEF WT 
cells; after 2 h cycloheximide treatment, the HA-ATF3 level was significantly 
reduced in the absence of Pin1, while only a slight reduction was observed in MEF 







Fig 3.31: Pin1 stabilizes ATF3. 
(A) Western blot was carried out to determine the protein levels of ATF3 and Pin1 in LβT2 cells 
transfected with pCS2+ empty vector or pCS2+ Pin1 expression vector; GAPDH is shown as a loading 
control. (B) RT-PCR analysis of ATF3 mRNA levels was carried out in LβT2 cells transfected with 
pCS2+ empty vector or pCS2+ Pin1 expression vector; β-actin was used as an internal control. All 
transfections were carried out in duplicate. (C) Western blot was carried out to determine the protein 
levels of HA-ATF3 and Pin1 in MEF WT or Pin1 –/– cells transfected with HA-ATF3 expression 
vector after exposure to 100 μg/mL cycloheximide for 0-6 h, as indicated; α-tubulin (Tub) is shown as 









3.15 GnRH stimulates ATF3 transcription  
Previous reports by others have shown that GnRH induces ATF3 expression in the 
immature gonadotrope αT3-1 cells (Xie et al., 2005; Mayer et al., 2008). The 
upregulation of ATF3 by GnRH was also observed in the mature gonadotrope LβT2 
cells (Fig 3.32A, B and C). As in αT3-1 cells, ATF3 mRNA and protein were easily 
detected in LβT2 cells after 30 min GnRH treatment and both peaked at 1 h (Fig 
3.32B and C). The increase in ATF3 mRNA diminished rapidly after the peak, while 
its protein had a sustained high level for several hours (Fig 3.32B and C). However, 
the induction of ATF3 by GnRH in LβT2 cells was significantly higher than that in 
αT3-1 cells (Fig 3.32A). In order to examine whether GnRH also has a protective 
effect on ATF3 protein, HA-tagged ATF3, which is not under the control of native 
ATF3 promoter was transfected into LβT2 cells in order to exclude the effect of 
GnRH on its gene transcription, and the cells were then treated with GnRH for 
various times. Western blotting showed that the exogenous ATF3 protein remained 
virtually unchanged in GnRH-treated LβT2 cells (Fig 3.32D), which indicates that 
GnRH may not stabilize ATF3 protein. Taken together, these results suggest that the 











Fig 3.32: GnRH upregulates ATF3 transcriptionally. 
(A) Western blot was carried out to determine the protein level of ATF3 in αT3-1 and LβT2 cells 
following 100 nM GnRH treatment for 0 or 2 h; GAPDH is shown as a loading control. (B) Western 
blot was carried out to determine the protein level of ATF3 in LβT2 cells following 100 nM GnRH 
treatment for 0-6 h; α-tubulin (Tub) is shown as a loading control. (C) RT-PCR analysis of ATF3 
mRNA levels was carried out in LβT2 cells following 100 nM GnRH treatment for 0-6 h; β-actin was 
used as an internal control. (D) Western blot was carried out to determine the protein level of 
HA-ATF3 in LβT2 cells transfected with the same amount of HA-ATF3 expression vector after 







3.16 Pin1, c-Jun and ATF3 form a complex in gonadotropes 
As reviewed in Section 1.5.2, ATF3 and c-Jun can form a heterodimer to activate 
gene transcription. Moreover, c-Jun itself is also a GnRH-responsive immediate early 
gene, and GnRH activates its expression in a trend similar to ATF3 induction in both 
the immature and mature gonadotropes (Wurmbach et al., 2001; Fig 3.33A and B). 
GnRH treatment was seen to lead to the recruitment of ATF3 and c-Jun to the dual 
CRE on the human αGSU promoter (Xie et al., 2005). Since c-Jun is an established 
Pin1 binding partner (Wulf et al., 2001) and in this study it has been found that ATF3 
also interacts with Pin1, it was speculated that Pin1, c-Jun and ATF3 might form a 
tripartite complex in gonadotropes. Co-immunoprecipitation assays showed that both 
Pin1 and ATF3 are present in the c-Jun antibody precipitates from untreated or 
GnRH-treated LβT2 cell lysates, and that GnRH enhances the interaction between 
c-Jun and ATF3, presumably through increasing their protein levels (Fig 3.33C). In 
order to test whether the three proteins exist in the same complex, 
co-immunoprecipitation using ATF3 antibody was performed and Pin1 and c-Jun 
were found in the precipitates (Fig 3.33D). These results indicate that Pin1, ATF3 and 









Fig 3.33: Pin1, c-Jun and ATF3 form a complex in gonadotropes. 
(A) Western blot was carried out to determine the protein levels of ATF3 and c-Jun in αT3-1 and LβT2 
cells following 100 nM GnRH treatment for 0 or 2 h; GAPDH is shown as a loading control. (B) 
Western blot was carried out to determine the protein level of c-Jun in LβT2 cells following 100 nM 
GnRH treatment for 0-6 h; α-tubulin (Tub) is shown as a loading control. (C) Cell lysates from LβT2 
cells treated with 100 nM GnRH for 0 or 4 h were immunoprecipitated using antibody to c-Jun or using 
normal IgG as control; Western blot was carried out to determine levels of c-Jun, ATF3 and Pin1 in the 
input and precipitated samples. (D) Cell lysates from LβT2 cells treated with 100 nM GnRH for 0 or 4 
h were immunoprecipitated using antibody to ATF3 or using normal IgG as control; Western blot was 





















3.17 ATF3 is SUMOylated 
Besides its role in activating ATF3 transcription, GnRH was also able to increase the 
SUMOylation of ATF3 in LβT2 cells (Fig 3.34A). As reviewed in Section 1.6.2, most 
proteins are conjugated to SUMOs via lysines within ψKXE (ψ denoting a 
hydrophobic residue) consensus motifs (Rodriguez et al., 2001; Bernier-Villamor et 
al., 2002). Therefore, in order to identify the SUMO acceptor sites in ATF3, a series 
of ATF3 mutants were created in which lysines within the ψKXE motif were mutated 
to a non-SUMOylatable arginine, K42R, K78R, K107R, K110R, K120R and K136R. 
The ATF3 wild type and these mutant expression vectors, together with 
Myc-SUMO-1, were transfected into LβT2 cells and the lysates were 
immunoprecipitated using HA antibody. Analysis of the precipitates by Western blot 
showed that the upper band between the 50 and 37 kDa markers disappeared when 
Lys 78 was mutated to Arg, whereas the K42R mutation eliminated the lower band 
between 50 kDa and 37 kDa (Fig 3.34B). Thus, the substitutions of Lys to Arg 
indicate that K42 and K78 are two acceptor sites in ATF3 for SUMO modification. 
Moreover, it was found that ATF3 was specifically targeted by SUMO-1, while SF-1 
can be conjugated to either SUMO-1 or SUMO-2/3 as reported (Fig 3.34C; Komatsu 












Fig 3.34: ATF3 is SUMOylated in LβT2 cells. 
(A) Cell lysates from LβT2 cells following transfection of Myc-SUMO-1 expression vector alone or 
together with Flag-ATF3 expression vector and exposure to 100 nM GnRH for 0 to 6 h, as marked, 
were immunoprecipitated using anti-Flag M2 beads; the precipitated samples were analyzed by 
Western blot using rabbit anti-Myc antibody, and the input samples were analyzed by Western blot 
using Flag antibody with α-tubulin (Tub) as a loading control. (B) Cell lysates from LβT2 cells 
following transfection of Myc-SUMO-1 expression vector together with WT HA-ATF3, HA-ATF3 
K42R, K78R, K107R, K110R, K120R, or K136R expression vector were immunoprecipitated using 
mouse anti-HA antibody; the precipitated samples were analyzed by Western blot using rabbit 
anti-Myc and anti-HA antibodies, and the input samples were analyzed by Western blot using HA 
antibody with GAPDH as a loading control. (C) Cell lysates from LβT2 cells following transfection of 
Myc-SUMO-1, Myc-SUMO-2 or Myc-SUMO-3 expression vector together with Flag-ATF3 or Flag 
SF-1 expression vector, as marked, were immunoprecipitated using anti-Flag M2 beads; the 
precipitated samples were analyzed by Western blot using rabbit anti-Myc antibody. The SUMOylated 
forms of ATF3 are marked with triangles on the left. It should be noted that SUMOylation at different 
lysines can cause slight difference in electrophoresis mobility (Tiefenbach et al., 2006). 
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CHAPTER 4   DISCUSSION AND CONCLUSIONS 
4.1 Reproductive abnormalities in Pin1 knockout mice 
In an early report, it was found that male and female Pin1 knockout mice are infertile 
when mated together, and that both Pin1-deficient males and females are subfertile 
when mated with wild type mice (Atchison et al., 2003). Further investigation of the 
reproductive organs has revealed that the number of germ cells in newborn Pin1 
knockout mice testes and ovaries is significantly fewer than that in wild type or Pin1 
–/+ mice (Atchison et al., 2003). Immunohistochemistry study and 
5-bromodeoxyuridine (BrdU) incorporation assay suggested that the severe reduction 
in gamete number in the absence of Pin1 could result from the prolonged cell cycle 
and impaired cell proliferation of primordial germ cells (PGCs), which are precursors 
of gonocytes and oocytes undergoing proliferation and expansion during and after 
their migration to the gonads from 8.5 to 13.5 days post coitum (dpc) (Atchison et al., 
2003). That report highlighted cell proliferation defects in the gonads of Pin1 
deficient mice that occur in the very early developmental stage, before the 
establishment of hypothalamic pituitary gonadal axis. A later study carried out by the 
same group reported that Pin1 also plays an important role in maintaining 
spermatogonia in adult testes (Atchison and Means, 2003). Pin1-knockout mice 
exhibit a gradual depletion of spermatogonia, which leads to spermatocyte and 
spermatid degeneration, and eventually complete germ cell loss and empty 
seminiferous tubules by the age of 14 months, although the remaining gonocytes in 
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Pin1 –/– testis were observed to be able to initiate and complete the entire 
spermatogenic process in 1 week old mice (Atchison and Means, 2003). A study 
conducted by Liou et al. also revealed a series of very similar phenotypes in Pin –/– 
male mice, including testicular atrophy, seminiferous tubule degeneration, and 
complete loss of mature sperm in the lumen by the age of 15-18 month (Liou et al., 
2002). These two reports indicate that Pin1 may have mutiple roles in regulating 
fertility in adults as well as during early stages of development. 
Since in many different genetic mouse models a testis degeneration phenotype is 
correlated with increased germ cell apoptosis, TUNEL (Terminal deoxynucleotidyl 
transferase-mediated dUTP nick-end labeling) assays in 3 and 7 month old wild type 
and Pin1 –/– mice were carried out by Atchison and Means to detect apoptotic cells. 
However, the results showed lack of increased germ cell apoptosis in the absence of 
Pin1 (Atchison and Means, 2003). Given the previous study performed by this group 
showing the role of Pin1 in regulating PGCs proliferation (Atchison et al., 2003), they 
speculated that Pin1 could also regulate spermatogonial proliferation in adult testis 
(Atchison and Means, 2003). In addition, Liou et al have demonstrated that this testis 
atrophy is not due to the smaller body weight of Pin1 –/– male adults because by 3-5 
month of age their average body weight is not significantly less than that of wild type 
controls, but the average weight of Pin1 –/– testes is only 56% of that of wild type 
testes (Liou et al., 2002). Therefore, the mechanisms by which these phenotypes 
occurred in Pin1 –/– testis are less clear. However, given that during the mouse 
embryo development the expression of gonadotropin genes is initiated after GnRH 
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delivery to the pituitary, which starts around e16.5, and that the hypothalamic 
pituitary gonadal axis is active in both males and females during the midtrimester of 
the fetal period and the early postnatal period (Japon et al., 1994; Grumbach and 
Styne, 2003), it is reasonable to consider that the mechanism responsible for the adult 
phenotype involve Pin1 regulation of the gonads through its action on gonadotropins 
synthesis. 
Interestingly, some of the reported Pin1 –/– testis phenotypes are largely mirrored in 
FSHβ knockout mice, such as the reduced testis size (beginning at 2 weeks of age and 
continually through the adult age), decreased fertility, decreased seminiferous tubule 
size (at 8-9 weeks), while germ cells in FSH–/– testis also maintain the ability to 
complete spermatogenesis (Kumar et al., 1997). It has also been reported that 
expression of transgenic FSH in gonadotropin-deficient hypogonadal mice stimulates 
the postnatal cellular development in seminiferous tubules and increases total 
spermatogonia proliferation (Haywood et al., 2003). Furthermore, reduced testis size 
was also seen in LHβ knockout male mice (Ma et al., 2004). Since the FSH and LH 
pathways are complexly interconnected in vivo and the two hormones act 
synergistically in regulating spermatogonia and preventing germ cell degeneration 
(Russell et al, 1993; Zirkin et al., 1994), it is very possible that some of the effects of 
Pin1 on testis are exerted through regulating LH and FSH production.  
The present study has demonstrated that Pin1 is required for gonadotropin β subunit 
gene transcription. This finding, together with regulation of PGC proliferation by Pin1, 
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suggests that Pin1 is diversely involved in different aspects of reproductive control, 
which is entirely in accordance with the nature of its effect: a commonly used 
mechanism involved in signal transduction through converting a target into different 
structure after phosphorylation. Therefore, it is still highly possible that Pin1 could 
also have additional roles at other points along the reproductive axis.  
4.2 Pin1 is involved in gonadotropin synthesis through its action on specific 
transcription factors  
In present study it has been shown that in gonadotropes Pin1 over-expression 
increases the basal and GnRH-induced LHβ and FSHβ gene transcription, while 
knock-down of Pin1 by siRNA results in decreased expression of LHβ and FSHβ (Fig 
3.1-3.4). Pin1 regulates gonadotropin β subunit gene transcription through targeting 
the specific transcription factors SF-1, Pitx1 and Egr-1, and modulating their stability 
or protein–protein interactions. These findings demonstrate for the first time an 
essential role of Pin1 in gonadotropin production and reveal the molecular 
mechanisms underlying some of the reproductive abnormalities in Pin1 knockout 
mice.  
The activity of transcription factors is characteristically regulated by various 
post-translational modifications. One such modification is the cis/trans isomerization 
of phosphorylated Ser/Thr-Pro bonds carried out by Pin1 together with 
proline-directed serine and threonine kinases (e.g., CDKs or MAPKs), which together 
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lead to conformational change in target protein and alteration in the transactivation 
potential of the transcription factor via changing its stability, protein–protein 
interaction, protein-DNA interaction, or intracellular localization.  
The known transcription factors targeted by Pin1 include c-Jun (Wulf et al., 2001), 
c-Fos (Monje et al., 2005), SRC-3/AIB1 (Yi et al., 2005), c-Myc (Yeh et al., 2004), 
β-catenin (Ryo et al., 2001), p53 (Zacchi et al., 2002; Zheng et al., 2002; Wulf et al., 
2002), p73 (Mantovani et al., 2004), p65/Rel (Ryo et al., 2003) and 
interferon-regulatory factor 3 (IRF3) (Saitoh et al., 2006). In many cases, the 
involvement of Pin1 in various biological events is mediated through its actions on 
specific transcription factors. For example, Pin1 plays an important role in cell growth 
control and oncogenesis through augmenting transactivation by c-Jun and promoting 
the translocation of β-catenin from cytoplasm to nucleus to regulate the expression of 
cyclin D1 (Wulf et al., 2001; Liou et al., 2002; Miyashita et al., 2003; Ryo et al., 
2001). Pin1 participates in cell cycle arrest and apoptosis through cooperating with 
genotoxic stresses to increase stability and nuclear accumulation of p53 and p73, 
ultimately upregulating their target genes including BCL2-associated X protein (Bax), 
p53-induced gene 3 (PIG3) and p53-regulated apoptosis-inducing protein 1 (p53AIP1) 
(Zacchi et al., 2002; Zheng et al.,2002; Mantovani et al., 2004). The regulatory 
function of Pin1 in innate antiviral response is achieved by altering the conformation 
of IRF3 so that IRF3 is more easily targeted by the ubiquitination machinery and 
finally degraded by the proteasome, leading to downregulation of its downstream 
interferon β (INFβ) (Saitoh et al., 2006). In this study it has been shown that Pin1 also 
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participates in gonadotropin β subunit gene transcription through its effects on the 
transcription factors SF-1, Pitx1 and Egr-1.  
4.2.1 Pin1 is present on the promoters of both gonadotropin β subunit genes 
In this study, ChIP experiments demonstrated that Pin1 is present on the promoters of 
both gonadotropin β subunit genes (Fig 3.8). Since Pin1 itself is not a DNA binding 
protein, it is presumably recruited to promoter region through specific transcription 
factors, such as c-Jun, SF-1, Pitx-1 and/or Egr-1, with which it interacts. Previous 
studies by others have revealed that, although barely detectable under non-stimulated 
condition, Pin1 is recruited to p53 binding element in the p21 and BAX promoters 
after UV or etoposide treatments, which are known to increase the interaction 
between Pin1 and p53 (Mantovani et al., 2007). However, the present study has 
shown that Pin1 binds to gonadotropin β subunit gene promoters without GnRH 
stimulation, which could be due to the fact that some of the specific transcription 
factors such as SF-1 are already phosphorylated at Ser/Thr-Pro motif under normal 
culture condition (Hammer et al., 1999). The possible reason that 4 h GnRH-treatment 
did not obviously increase the association of Pin1 with the DNA could be that the 
enhancement of Pin1/DNA binding occurs at earlier time points, since the 
downstream kinases are rapidly activated by GnRH. Alternatively, the increased 
interaction between Pin1 and the phosphorylated transcription factors after GnRH 
stimulation could lead to conformational change of the promoters (e.g., forming a 
loop structure) since Pin1 and these transcription factors already sit on, maybe 
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different regions of, the promoters without GnRH treatment, but the amount of Pin1 
on the promoter is not changed.  
4.2.2 Effect of Pin1 on the transactivation function of these transcription factors 
The present study has shown that Pin1 acts synergistically with SF-1, Pitx1 and Egr-1 
to activate downstream gene promoters (Fig 3.12-3.14). These results clearly suggest 
that Pin1 is required for these gonadotropin β subunit gene transcription factors to 
acquire their fully active conformation. Since the two promoters both contain SF-1 
binding sites and Pitx1 bindig sites, it might be expected that Pin1/SF-1 or Pin1/Pitx1 
should display positive transcriptional cooperation on both of the promoters. However, 
the synergy appears to be promoter-context specific. Pin1 and SF-1 exhibit obvious 
synergy on the LHβ promoter, but not the FSHβ promoter, while Pin1 and Pitx1 
synergistically activate the FSHβ promoter, but not the LHβ promoter (Fig 3.12-3.14). 
As reviewd in Section 1.2.2, SF-1 plays a predominant role in LHβ transcription, but 
transcription regulation of FSHβ by SF-1 may be more indirect; while Pitx1 exerts its 
effect on LHβ transcription partly through SF-1 (Ingraham et al., 1994; Ikeda et al., 
1995; Keri and Nilson, 1996; Halvorson et al., 1996; Tremblay et al., 1998; Tremblay 
et al., 1999). The reason for this promoter-specific synergism could be that the mere 
simultaneous recruitment of Pin1 and non-master-regulatory transcription factor may 
not be sufficient for effective synergistic activation. In addition, overall topology 
differences between the two promoters regarding the close proximity of SF-1 or Pitx1 
binding elements to the transcription start site or other cis-acting elements, and 
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interplay with other protein cofactors could also influence the level of cooperativity 
on specific promoters.  
4.2.3 Pin1 promotes ubiquitination of SF-1, which is required for SF-1 cofactor 
recruitment 
Most strikingly, it was found in the present study that the SF-1 protein level is clearly 
reduced after Pin1 over-expression, which contrasts with the opposite effect on Pitx1 
(Fig 3.15), even though SF-1 is functionally activated by Pin1 on the LHβ gene 
promoter (Fig 3.12). Previous studies by two groups have indicated that SF-1 is 
poly-ubiquitinated (Walsh and Shupnik, 2009; Chen et al., 2007) and in this study it 
has been further shown that SF-1 ubiquitination is dependent on its phosphorylation 
of Ser 203 and Pin1. Furthermore, ubiquitination of SF-1 facilitates the interaction 
between SF-1 and its cofactor Pitx1 (Fig 3.25). These findings not only uncover 
evidence for the existence of post-phosphorylation events on SF-1, but also reveal a 
novel mechanism by which post-translational modifications modulate transcriptional 
activity of SF-1. 
The Ser 203 which is recognized and bound by Pin1, locates in the hinge region of 
SF-1, adjacent to helix 1 (Fig 1.7), and its phosphorylation has been shown previously 
to induce major conformational change in the protein, as indicated by change in 
protease sensitivity (Desclozeaux et al., 2002). That study also indicated that the Ser 
203 phosphorylation enhances the activity of this hinge/helix 1 region and cofactor 
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recruitment, likely as a consequence of the change in conformation (Desclozeaux et 
al., 2002). It is conceivable that this conformational change is the Pin1-induced 
isomerization which increases the accessibility of SF-1 to the ubiquitin-conjugation 
machinery, leading to its interaction with Pitx1 and ultimately to proteasome mediated 
degradation.  
The finding that GnRH increases SF-1 ubiquitination is consistent with a recent report 
by Walsh and Shupnik (2009). Suppression of GnRH-induced SF-1 ubiquitination by 
the ERK-specific inhibitor, U0126, suggests that the signal could stem from activation 
of ERK2, which has been shown to phosphorylate SF-1 both in vivo and in vitro 
(Fowkes et al., 2003; Hammer et al., 1999; Desclozeaux et al, 2002). However, SF-1 
is also reportedly phosphorylated by CDK7 and TFIIH (Lewis et al., 2008). 
Activation of CDK7 relies on its phosphorylation at Thr 170 and association with 
cyclin H and MAT1 to form a ternary complex (Garrett et al., 2001). Although the 
association of these proteins in the gonadotropes has not been examined, CDK7 is 
phosphorylated at Thr 170 even without GnRH stimulation (Fig 3.20A), indicating 
that CDK7 may be constitutively active in the gonadotrope cells. This level of 
activation is likely responsible for the maintenance of phosphorylation of a small pool 
of SF-1 to ensure basal gene transcription, and would explain an earlier report that 
SF-1 is constitutively phosphorylated following its expression in MCF7 and COS 
cells (Hammer et al., 1999). These findings are in line with the results in the present 
study showing that without GnRH stimulation, ubiquitination of SF-1 is also 
dependent on phosphorylation by CDK7. 
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A number of recent works have highlighted the role for ubiquitination in 
transcriptional regulation, and this likely involves both mono-ubiquitination which 
increases certain protein–protein interactions, as well as poly-ubiquitination through 
various linkages, only some of which are recognized by the proteasome, and may 
facilitate promoter clearance (Sun and Chen, 2004; Hicke 2001; Muratani and Tansey, 
2003; Pickart and Fushman, 2004; Wu et al., 2007; Sims and Cohen, 2009; Xu et al., 
2009; Wang et al., 2008). In the present study it has been shown that SF-1 is modified 
by both mono-ubiquitination and poly-ubiquitination. The poly-ubiquitinated chains 
on SF-1 are linked through either Lys 48 or Lys 63 in ubiquitin, the Lys 63 linkage 
being apparently more abundant (Fig 3.24). It should be noted that poly-ubiquitination 
editing can occur, whereby ubiquitin is first Lys 63-linked and then undergoes a 
change to Lys 48 linkages that target its substrate protein for degradation by the 
proteasome, such that unconventional ubiquitin chains can also lead to proteasomal 
degradation (Newton et al., 2008; Xu et al., 2009). For example, the zinc finger 
protein A20 functions as an ubiquitin-editing enzyme, which first cleaves Lys 
63-linked poly-ubiquitin chains and then conjugates Lys 48-linked poly-ubiquitin 
chains to enable proteasomal degradation, toward the downstream effector or adapter 
proteins like RIP1 and TRAF6 in the tumor necrosis factor receptor (TNFR) pathway 
or Toll-like receptor 4 and interleukin-1 receptor (TLR4/IL-1R) pathways to control 
the strength and duration of inflammatory signaling (Wertz et al., 2004; Shembade et 
al., 2010). Therefore, it is also reasonable to speculate that there is an 
ubiquitin-editing enzyme for SF-1, which can remove Lys 63-linked ubiquitin chains 
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from SF-1 after the cofactor recruitment, and add Lys 48-linked ubiquitin chains on 
SF-1, leading to its proteasome degradation and the eventual promoter clearance of 
the transcription machinery. 
It has been demonstrated in this study that SF-1 ubiquitination increases SF-1 
interaction with Pitx1 and requires phosphorylation of S203 (Fig 3.25 and 3.29), 
which was shown previously to increase SF-1 interaction with various cofactors, 
while others have shown that SF-1 at the LHβ promoter is indeed ubiquitinated 
(Hammer et al., 1999; Desclozeaux et al., 2002; Walsh and Shupnik, 2009). Given 
that relatively large amounts of mono-ubiquitinated SF-1 are detected, and that the 
mono-ubiquitination is also increased by GnRH, it is likely that this modification 
might signal the increased interaction with Pitx-1. The poly-ubiquitination and 
eventual clearance of SF-1 from promoter is likely important for the next round of 
transcription initiation, as shown for other regulated transcriptional activators (Reid et 
al., 2003; Wu et al., 2007). This is a similar mechanism to that which our group 
showed for GnRH-induced ubiquitination of ERα in the activation of the LHβ gene 
promoter, although it involves a very different mechanism, in which GnRH 
upregulates the ubiquitin conjugating enzyme, ubc4, which targets ERα (Luo et al., 
2005). This pathway of SF-1-Pitx-1 interaction, clearance and subsequent degradation 
via Pin1-stimulated ubiquitination would explain the requirement for Pin1 and yet its 
reduction in SF-1 protein levels.  
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This model is consistent with reports in which ubiquitination of SRC-3 is dependent 
on GSK3-induced phosphorylation, and controls both its transactivation and its 
clearance from the promoter before the next round of transcriptional initiation. It has 
been proposed that the transition from mono-to poly-ubiquitination of this activator, 
which takes place during transcription, serves as a clock to regulate its lifetime (Wu et 
al., 2007). In a different study, it was shown that Pin1 interacts with phosphorylated 
SRC-3, regulates SRC-3 cellular turnover and enhances the functional interaction 
between SRC-3 and CBP/p300, while both proteins activate synergistically estrogen 
response element- and progesterone response element-driven luciferase reporter genes 
(Yi et al., 2005). These clearly suggest that the ubiquitin proteasome degradation of 
SRC-3 is phosphorylation- and Pin1-dependent. 
Pin1 has been linked to promoting ubiquitin-proteasome-mediated degradation of 
other proteins, for example the turnover of BCL2, c-Myc and cyclin E are increased 
following Pin1 interaction (Phan et al., 2007; Basu and Haldar, 2002; Sears, 2004; 
Yeh et al., 2006). Negative regulation by Pin1-induced ubiquitination has also been 
shown for the death associated protein, Daxx, which inhibits the apoptotic response as 
a result of its proteasomal degradation (Ryo et al., 2007). A recent report has 
indicated that ubiquitination of Smad proteins occurs after binding by Pin1, as a result 
of the phosphorylated Smad’s increased interaction with the E3 ligase Smurf, which is 
negatively regulates Smad activity (Nakano et al., 2009). A change in protein–protein 
interactions in this pathway, as a result of Pin1 binding, has also been shown for the 
RNA polymerase binding protein, Che-1, which is degraded in response to apoptotic 
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stimuli after Pin1-induced conformational changes, allow it to interact with the E3 
ligase, HDM2 (De Nicola et al., 2007). However in all of these reports, the outcome 
of the Pin1 mediated ubiquitination is negative regulation. The results shown in 
present study, as well as those pertaining to the activity of SRC-3, indicate that the 
Pin1-induced isomerization allows access to various E3 ligases which promote 
assorted ubiquitin linkages with diverse outcomes.  
4.2.4 Effect of Pin1 on protein stability of Pitx1  
The current study has revealed that the action of Pin1 on SF-1 is not universal, as the 
same drop in the protein levels of Pitx1 and Egr-1 were not observed, despite its 
interaction with both proteins in the LHβ promoter. On the contrary, both endogenous 
and exogenous tagged Pitx1 protein levels are increased after Pin1 over-expression 
(Fig 3.15), indicating that Pin1 has a positive role in Pitx1 protein level. It is highly 
possible that Pin1 stabilizes Pitx1 protein through protecting it from 
ubiquitin-proteasome-mediated degradation machinery, since poly-ubiquitinated Pitx1 
has been detected in gonadotropes after treatment with the proteasome inhibitor, 
MG132(Fig 3.25C). The augmentation by Pin1 of Pitx1 transactivation towards the 
FSHβ gene promoter could be a consequence of Pin1-induced Pitx1 stabilization (Fig 
3.13). The enhancement of transcription factor activity by Pin1 through increasing its 
stability has been exemplified by other transcription factors, such as β-catenin (Ryo et 
al, 2001), p53 (Zacchi et al, 2002; Zheng et al, 2002), p73 (Mantovani et al., 2004) 
and p65/Rel (Ryo et al., 2003). It has been shown that Pin1 functions as a positive 
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regulator of β-catenin by interfering with its interaction with the APC complex, 
resulting in its stabilization and thus upregulation of its target genes, such as c-myc 
and cyclin D1 (Ryo et al, 2001). Pin1 also targets p53 on phosphorylated Ser/Thr-Pro 
motifs, generated by stress-induced kinases, and protects it from the E3 ubiquitin 
ligase murine double minute 2 (Mdm2), which leads to p53 stabilization and 
upregulation of its downstream checkpoint control genes (Zacchi et al, 2002; Zheng et 
al, 2002). Thus, Pin1 may act as a coactivator during gene transcription, protecting 
transcription factors from degradation and allowing them to participate in promoter 
binding and gene activation. 
4.3 Regulation of Pin1 by GnRH 
A number of studies have demonstrated the function of Pin1 through its interaction 
partners in regulating various biological process and disease development (Lu, 2004; 
Lu and Zhou, 2007). Therefore, the investigation of the regulation of Pin1 activity 
could lay the foundation for exploring Pin1-specific small molecule inhibitors or 
activators for therapeutic purposes. This study has demonstrated that GnRH increases 
Pin1 expression levels and regulates its activity through both phosphorylation and 
dephosphorylation which, for the first time, indicates that Pin1 is a controllable 
mediator in signal transduction pathways. 
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4.3.1 Expression of Pin1 is induced by GnRH 
In agreement with the results showing that Pin1 upregulates gonadotropin β subunit 
gene transcription, we have also shown that GnRH stimulates Pin1 expression (Fig 
3.5; Luo et al., 2010). It has been reported that Pin1 expression is mediated through 
the activation of E2F by various oncoproteins including Ras, possibly involving also 
SP1 which can interact with E2F and might bind to the two GC boxes on Pin1 
promoter (Ryo et al., 2002). In the gonadotrope, the Ras-MEK-pathway is activated 
by GnRH, which stimulates E2F (Naor, 2009; Berkovich and Ginsberg, 2001) and 
SP1 mediates some of the GnRH responsiveness of the LHβ gene (Kaiser et al., 1998), 
suggesting that this is a likely mechanism of elevation of Pin1 mRNA levels in 
gonadotrope cells by GnRH. 
4.3.2 Phosphorylation of Pin1 is regulated by GnRH 
We have also demonstrated that GnRH rapidly increases Pin1 phosphorylation at Ser 
16, which was reported to inactivate Pin1 by preventing its interaction with the 
substrate and its translocation into the nucleus (Lu et al., 2002). These apparently 
conflicting actions of GnRH on Pin1 activity are reconciled by the discovery that 
GnRH also dephosphorylates Pin1 through calcineurin (Luo et al., 2010). Calcineurin 
is the calmodulin-activated protein Ser/Thr phosphatase 2B (PP2B), which is 
upregulated by GnRH (Fig 3.5; Lim et al., 2007). It is conceivable that the 
phosphorylation of Pin1 on Ser 16 residue results in the translocation of Pin1 out of 
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the nucleus (Lu et al., 2002), which would allow calcineurin, which is localized in the 
cytoplasm to interact with and dephosphorylate Pin1, thereby allowing the active Pin1 
to return back into the nucleus. Therefore, the dephosphorylation of Pin1 by 
calcineurin presumably reactivates Pin1, so providing an additional distinct and 
regulatable pathway through which GnRH ensures sufficient levels of active nuclear 
Pin1. This finding is the first to link these two proteins, Pin1 and calcineurin, and 
indicates that Pin1 activity can be regulated by the same extracellular signals that 
activate the phosphorylation cascade targeted by Pin1. 
4.4 Regulation of SF-1 transcriptional activity by the crosstalk between various 
post-translational modifications 
Phosphorylation by the MAPK signal pathway of SF-1 at Ser 203, located in the AF-1 
domain of the hinge region of this protein, was first identified in 1999, and notably, 
this modification is required for recruitment of cofactors to maximally activate SF-1 
downstream target genes (Hammer et al., 1999; Fowkes et al., 2003; Lewis et al., 
2008; Yang et al., 2009). Furthermore, another functional consequence of this 
phosphorylation is in decreasing the sensitivity of SF-1 to protease (Desclozeaux et al., 
2002). However, the mechanism through which Ser 203 phosphorylation modulates 
SF-1 activity remained unclear until the present findings uncovering its additional 
post-phosphorylation modification. As discussed in Section 4.2.3, phosphorylation of 
SF-1 at Ser 203 is required for its interaction with Pin1 and its ubiquitination, which 
promote the recruitment of Pitx1 and upregulate downstream gene transcription.  
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We have also found that ubiquitin targets SF-1 at Lys 119, which is also targeted by 
SUMO (Fig 3.22). Previous studies by others revealed that SF-1 is SUMOylated at 
two conserved lysines (Lys 119 and Lys 194) that locate adjacent to the DBD and 
LBD respectively, and this modification repressesed SF-1 transactivation function 
(Komatsu et al., 2004; Lee et al., 2005; Campbell et al., 2008; Yang et al., 2009). This 
was attributed to the SUMOylation at Lys 194 which has been shown to reduce Ser 
203 phosphorylation, decrease coregulator binding, and cause a selective loss of 
binding to certain target genes (Yang et al., 2009; Campbell et al., 2008). In contrast, 
it has been shown in present study that SF-1 SUMOylation is not affected by Ser 203 
phosphorylation but SUMOylation at Lys 194 is a prerequisite for SUMOylation at 
Lys 119, which have been indicated also in other reports (Komatsu et al., 2004; Yang 
et al., 2009). Furthermore, this study also has demonstrated that ubiquitination of SF-1 
at Lys 119 enhances, while SUMOylation inhibits, its interaction with Pitx1 which 
functions as a crucial coactivator in gonadotropin gene expression (Fig 3.25; 
Tremblay et al., 1999). These results reveal that the competition between SUMO and 
ubiquitin for the same Lys 119 in SF-1 affects SF-1 transcriptional activity in an 
opposite way. Thus, the transcriptional activity of SF-1 is dynamically and tightly 
modulated by a pathway of post-translation modifications. The de-SUMOylation on 
Lys 194 which facilitates Ser 203 phosphorylation allows Pin1-mediated 
isomerization, enabling the subsequent Lys 119 ubiquitination, to facilitate the 
interaction with its specific coactivator, Pitx1, and promoter activation. 
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4.5 Interaction between Pin1 and ATF3 
In this study it has been shown that Pin1 can bind to ATF3 (Fig 3.30). Inspection of 
the amino acid sequence of ATF3 reveals that this protein contains three Ser/Thr-Pro 
motifs, Ser 24-Pro, Thr 38-Pro, and Thr 162-Pro, which are potential Pin1 binding 
sites if phosphorylated (Lu, 2004; Lu and Zhou, 2007). However, to date the only 
reported phosphorylation in ATF3 occurs at a tyrosine residue (Stearns et al., 2004). 
We have tried to use mitotic phosphoprotein monoclonal 2 (MPM-2) antibody which 
can recognize pSer/Thr-Pro epitope on about 50 mitotic proteins (Westendorf et al., 
1994; Matsumoto-Taniura et al., 1996; Ding et al., 1997), to examine whether ATF3 
is phosphorylated on these Ser/Thr-Pro motifs. However MPM-2 antibody fails to 
immunoreact with purified ATF3 from untreated or GnRH-treated LβT2 cell lysates 
(data not shown), likely because ATF3 does not belong to the group of proteins which 
are phosphorylated during G2 and dephosphorylated at the end of mitosis (Renzi et al., 
1997; Shen et al., 1998). Therefore, we cannot exclude the possibility that ATF3 
could be phoshorylated at potential Pin1 binding sites. However, it has been 
demonstrated in some recent publications that Pin1 is able to bind to non-canonical 
motifs in its target proteins including cyclin E (Yeh et al., 2006) and BNIP-H 
(Buschdorfv et al., 2008), BPGAP1 (Pan et al., 2010). This finding widens the 
spectrum of Pin1 targets and raises another possibility that Pin1 could directly interact 
with ATF3 even if ATF3 is not phosphorylated at Ser/Thr-Pro motifs. In this study 
the observation that Pin1, c-Jun and ATF3 form a complex in gonadotropes also 
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suggests that Pin1 and ATF3 might interact with each other in an indirect manner with 
c-Jun serving as a bridge protein between them.  
4.6 The Effect of Pin1 on ATF3 protein level 
In the present study it has been found that in gonadotropes, Pin1 increases the protein 
level of ATF3 (Fig 3.31A). Although RT-PCR showed that Pin1 over-expression does 
not lead to an elevation of ATF3 mRNA (Fig 3.31B), the possibility should not be 
ruled out that Pin1 could activate ATF3 transcription, as ATF3 is a target gene of 
Egr-1 (Mayer et al., 2008), whose transactivation capacity towards LHβ gene 
promoter is augmented by Pin1 (Fig 3.14). As reviewed in Section 1.5.1, ATF3 
mRNA induction is usually transient, therefore changes in ATF3 mRNA levels, if 
occuring, could have gone undetected. 
Since in MEF cells the half life of ATF3 protein is much shorter in the absence of 
Pin1 (Fig 3.31C), and in gonadotropes GnRH activates Pin1 expression (Fig 3.5; Luo 
et al., 2010), it might be expected that GnRH could play a protective role in ATF3 
protein via Pin1. However, GnRH treatment does not affect ATF3 post-translationally 
in LβT2 cells (Fig 3.32D). This could be due to the fact that although Pin1 is required 
for maintaining a stable state of ATF3 protein, the amount of Pin1 is already 
sufficient in LβT2 cells. Moreover, based on the data presented in this study, we 
cannot exclude the possibility that Pin1 affects ATF3 protein stability indirectly; thus, 
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it is also likely that some ATF3 stabilizers or destabilizers regulated by Pin1 could be 
present in MEF cells but not gonadotropes.  
4.7 SUMOylation of ATF3 
SUMOylation has recently emerged as an important post-translational regulatory 
mechanism in controlling transcription factor activity (Gill, 2004; Geiss-Friedlander 
and Melchior, 2007). In this study it has been found that ATF3 is specifically targeted 
by SUMO-1 at Lys 42 and Lys 78 in gonadotropes (Fig 3.34). To date, three 
mammalian SUMO proteins SUMO-1, SUMO-2 and SUMO-3 have been detected 
(Schwarz et al., 1998; Azuma et al., 2003). Different SUMOs share redundant 
properties but also have some specific cellular functions (Gill, 2004; Hay, 2005; 
Geiss-Friedlander and Melchior, 2007). SUMO-1 shares 48% and 46% sequence 
identity with SUMO-2 and SUMO-3, respectively, while SUMO-2 and -3 are 96% 
identical to each other (Saitoh and Hinchey, 2000). The structural analyses have 
revealed that the three SUMO proteins adopt the compact and globular ubiquitin-like 
fold, and that the major difference between SUMO-1 and SUMO-2/3 are found in the 
second β-strand and the α-helix, which are key regions for binding to 
SUMO-interaction motifs on target proteins and mediating the transcriptional 
inhibitory properties of SUMOs (Bayer et al., 1998; Huang et al., 2004; Ding et al., 
2005; Chupreta et al., 2005; Hecker et al., 2006). Apparently, future work should 
focus on how the modification of ATF3 by SUMO-1 is translated into biological 
effects.  




The present study has demonstrated that Pin1 is required for the activation of basal 
and GnRH-stimulated gonadotropin β subunit gene transcription through interacting 
with the phosphorylated transcription factors SF-1, Pitx1 and Egr-1 and changing 
their stability, transcriptional activity, and/or protein–protein interactions. One of the 
mechanisms of this Pin1 action is through targeting SF-1, a key factor regulating all 
three gonadotropin subunit genes. Pin1-mediated SF-1 isomerization coordinates 
phosphorylation and ubiquitination, which facilitates Pitx1 binding, to increase SF-1 
transcriptional activity. Furthermore, Pin1 expression and activity are also regulated 
by GnRH, indicating that Pin1 is an integral part of GnRH signaling (Fig 4.1). 
This study has also shown that Pin1 forms a complex with the αGSU gene 
transcription factors, c-Jun and ATF3, and increases the protein level of ATF3 in 
gonadotropes, and that ATF3 is targeted by SUMO-1 at Lys 42 and Lys 78. These 
findings would lead to a better understanding of the transcriptional regulation of 
αGSU gene.  
Given that the transcription factors targeting the gonadotropin genes are also involved 
in regulatory mechanisms in other physiological systems, the study of Pin1 function 
in gonadotropin subunit gene expression enhances our understanding of its role Pin1 
in coordinating signaling by extracellular factors to gene transcription.  
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